WO1987003002A1 - Process for producing foaming composition - Google Patents
Process for producing foaming composition Download PDFInfo
- Publication number
- WO1987003002A1 WO1987003002A1 PCT/JP1985/000625 JP8500625W WO8703002A1 WO 1987003002 A1 WO1987003002 A1 WO 1987003002A1 JP 8500625 W JP8500625 W JP 8500625W WO 8703002 A1 WO8703002 A1 WO 8703002A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- water
- acid
- component
- mixed
- minutes
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Their preparation
- A23L2/40—Effervescence-generating compositions
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01N25/00—Biocides, pest repellants or attractants, or plant growth regulators, characterised by their forms, or by their non-active ingredients or by their methods of application, e.g. seed treatment or sequential application; Substances for reducing the noxious effect of the active ingredients to organisms other than pests
- A01N25/16—Foams
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
- A61K9/0007—Effervescent
Definitions
- the present invention relates to a foaming composition having excellent properties of breaking down and foaming in a short time.
- a base component a powdery acid compound
- an acid component powder are humidified and mixed with water in a separate clam, dried, and dried.
- Pharmaceutical ingredients are heated and compressed to produce effervescent tablets-However, according to the method of the French patent; ⁇ , humidified abalone: ⁇ ⁇ ⁇ ⁇ ⁇ , and humidified and dried
- ⁇ humidified abalone: ⁇ ⁇ ⁇ ⁇ ⁇
- humidified and dried The addition of the components increases the proportion of powder in the whole powder, and causes various inconveniences in tableting, such as scratching and crushing.
- the proportion of the “pulverized powder” increases, the fluidity becomes poor (over 40% or more), and the mixed powder flows from the hopper of the tableting machine, so that tableting may not be possible.
- Alkali bicarbonate may be added with less than 1% water, but the amount of drug and citric acid added will exceed the amount of alkali potassium bicarbonate.
- the amount of water added to the total weight is France It is the same as the addition of water of 0.5% or less of the patent, and as described above, only fine particles can be formed, so in tableting, the effect of the lubricant is weakened, Cause Various amounts of water are vaporized and granulated for the mixture of acid and alkali, but special equipment is required and this is not common. Also, humidification with water vapor takes a longer time than humidification with the addition of water, and it is difficult to control the amount of moisture absorption.
- the present inventors have developed a method for producing a foamed composition that quickly breaks down, foams quickly, and is easy to produce. Separation method: Blend the active ingredient in both sides, humidify each with about 0.5 to 6 ⁇ water, and mix them together. It has been found that the composition can be manufactured and further research has been made to complete the present invention:
- Akira Moto:. Yo solid carbonate ⁇ ⁇ alkali metal salts (. "Lambda component Bas than de, Arukari that component and Iu Moaru Y;) solid proof Group Karupon acid (: B component)
- B component solid proof Group Karupon acid
- the active ingredient-containing foaming composition characterized by mixing the C component with both, adding each with about 0.5 to 5% (w / w) of water, and then mixing.
- alkali metal alkali carbonate examples include alkali metal carbonate, alkali metal bicarbonate, and earth alkali metal carbonate.
- alkali metal examples include, for example, sodium and calcium
- examples of the alkaline earth metal include calcium, magnesium and the like.
- Specific examples of the alkali metal salt of carbonic acid include, for example, sodium carbonate and potassium carbonate, among which sodium carbonate is most preferred.
- alkaline earth metal salts include, for example, calcium carbonate, magnesium carbonate, and barium carbonate. Of these, calcium carbonate is preferred.
- the alkali metal carbonate of carbonic acid used in the present invention includes the above-mentioned compound-.
- the alkali metal salt of calcium sulfate Solid is used in the form of a solid. I like it
- arresting carboxylic acid there are:-basic, ', dihydrochloric', tribasic ⁇ , o, etc.,
- Examples of the basic alicyclic carboxylic acid include water S-acid, glycolic acid, etc.
- Examples of the dibasic aliphatic carboxylic acid include: Examples of the tribasic aliphatic carboxylic acids include tartaric acid, phthalic acid, maleic acid, maleic acid, malic acid, ligonic acid, and succinic acid. , Isocyanic acid and the like.
- the aliphatic carboxylic acid may be a mixture of the compounds described above. Among the aliphatic carboxylic acids, citrate anhydride is the most preferred.
- the active ingredient of the present invention includes, for example, pharmaceuticals, foods, agricultural chemicals, veterinary medicines, etc.-The pharmaceuticals include:-,, and ⁇ and vitamin C (ascorbic acid, L -Combination of sodium ascorbate, calcium ascorbate), paracetamol (acetominofen), aspirin (aceti; resalicylic acid), or a combination of two or more or comprehensive Vita Mi emission component:.?.. example, Vita Mi emissions ⁇ , ⁇ , ⁇ 3 ⁇ ; 3 ⁇ 4 , ⁇ 5, ⁇ 0, B 12 C, D .E, folic acid, minerals (I column, iron.
- the foods are as follows: ⁇ , tobacco powdered wine, aspa'retam O-L-aspartyl-L-phenylalanine methylester, acesulfame: 6-methyl- 1.2.3-oxoxathiazine-4- (3 ⁇ ) ) —Wonder 2.2—Dioxan .; Alkali metal salt, such as potassium, sa :: carin, sand, etc. b Submarine mineral, etc. Teas containing crude oil extract include:
- the amount is preferably about 6 ()% ( : weight) or less based on the foaming ingredient (A ingredient and B ingredient).
- Such pesticides include gibberellic acid and the like:
- the amount is preferably not more than about 60% (weight) with respect to the foaming ingredient (A ingredient and B ingredient).
- the animal 3 ⁇ 4 medicine for example, nitrofurazone, Sulphadimethoxine, furazolidone, sigma lutetrasin, etc.
- the amount is preferably less than about 60% (by weight) based on the foaming ingredients (component A and component B).
- the active ingredient of the present invention may be in the form of powder or granulated. Among them, granulated ones are preferred.
- the basic active ingredient is preferably mixed with the alkali metal salt of diacid (component A).
- Acidic active ingredients are preferably mixed with aliphatic carboxylic acids (component B).
- Neutral active ingredients can be mixed with either component A or component B, or both.
- composition of the present invention may be in the form of, for example, a tablet:
- the method for producing the foam composition of the present invention is described below.
- the active ingredient is mixed as necessary with the alkali metal salt of carbonate (A component), and the mixture is further mixed with the mixture, and the mixture is humidified with about 0.5 to 5% (wZft water.
- a component alkali metal salt of carbonate
- the mixture is further mixed with the mixture, and the mixture is humidified with about 0.5 to 5% (wZft water.
- the amount of water that is added is about 1 to 3% However, about 1 to 2% (wZv is preferred.)
- the water can be added with an organic solvent as desired. In this case, the ratio of water to the organic solvent is preferably about 1 to 1 but i to 4 (v / v).
- a coloring agent, a sweetener and the like are added to the water, and the resulting coloring agent is, for example, riboflavin, a synthetic coloring agent, such as tatrazine, sunset, etc.
- the sweetener includes, for example, saccharine aspartame, sand, and the like.
- C The wet method is to put water in a stirrer while stirring and spray. And a method in which a small amount of water is dropped while stirring in a stirrer.
- the active ingredient is mixed as necessary with the solid aliphatic carboxylic acid (component B), and the mixing agent is further mixed as necessary, and the mixture is mixed with about 0.5 to 5% (wZw) water. Add S.
- Examples of the composite include those similar to those used in the humidification of the above-mentioned components.
- the amount of water used is preferably about 1 to 3% (wZw), and more preferably about 1 to 2% (w / w).
- the water may be added with an organic solvent as desired, and may be used as the organic solvent and the amount of the organic solvent to be used: And the same amount used.
- a component and B component are separately humidified and then mixed.
- a mixing method mix in a stirrer such as Tatoba Vertical Granulator (Fuji Industry Co., Ltd., Japan) for about 3 to 5 minutes.
- the condyla-like shape obtained in the first step is attached to the following procedure, and the condyla is further passed through an 8-mesh (.JIS standard) sieve. It is preferable that the size be such that it does not pass through a 100-mesh (JIS standard) sieve.
- the condyla obtained in this manner is then subjected to a drying process.
- the drying method is, for example, about 40 ° in a vacuum drier (: about 60 °. 5 mmHg, drying for about 8 to 16 hours, drying for about 40 to 60 in a ventilation dryer for about 1 to 3 hours, and the like.
- a foamed condensate containing an acid component and an alkali component may be added with a roasted lubricant. This is because if the lubricant is mixed with the foamed granules as it is, it will tend to become a gallant gallary with static electricity When the lubricating agent is used, it is mixed with the acid component and sieved to prevent the lubricating agent from abrasion and reduce the effect of the lubricating agent. Therefore, the failure can be easily performed. Further, the foaming power of the obtained tablet can be enhanced by adding the alkali metal salt of carbonic acid which has been separately ablated.
- the tablet is compressed.
- Examples of the coloring agent include riboboflavin, evening trazine, sunset C7, and the like.
- examples of the above-mentioned flavors include, but are not limited to, lemony; lemony; For example, if the zipper or the rainpad is not used, it can be used as a flavor, such as tobasa, kan, ass tem, sand, etc. Examples of these include ⁇ s ⁇ s And t either times long times either, it is sodium glutamate, ⁇ acid seasoning, succinic acid, and powdered ash.
- the active ingredient is a veterinary drug, add emulsifier, etc., as a failure.
- the emulsifier ⁇ is sodium laurylsulfate, boric acid. Vinyl virolidone, polyethylene glycol. Polyester; alcohol-proofing ester; polyester, spandex, sandstone, etc .: For tableting. As a mixture to be used:
- Compression lubricants used in the event of failure include, for example, sodium stearate, sodium benzoate, polyethylene glycol 400, polyethylene glycol 600, and the like.
- the breakdown can be carried out according to the method generally used in the public domain itself-in the foamed composition obtained in this way, if the active ingredient is a medicament, the effective dose
- the composition containing the above drug is administered to a human.
- Bath tub% ⁇ Put foaming dissolving solution: Take a bath and absorb medicine from skin
- one tablet of ascorbic acid contains about 500 to 100 000 fT. Dissolve and dissolve.
- a composition containing an amount of the food to be an effective intake is used, for example, in the following manner.
- the solution is foamed in water and the solution is made into a suspension.
- tea containing crude drug extract is about 500 to 10
- the effervescent tablet of the present invention containing 100 mg to 40 ° to 80 °
- the foamed composition obtained according to the method of the present invention is a pesticide
- the artificial substance containing the pesticide which is to be an effective spraying device is, in most cases, the composition is put into water and foamed.
- Animal ffl The composition containing the drug is administered as follows:
- the solution When the water is ti-foamed in the water, the solution is used as a suspension, and this is drunk by the animal. The water is foamed in the water, and the solution is suspended in the water. i,; Enter ⁇ Foamed Tsuji, Dissolve Filter: Suspended;
- the condyla a large uniform condyle, when poured into water, is well foamed after filling into the bottom.
- the foam composition is condensed. In the place where you can make 5 pieces by crying, you can use a little water and it is easy to shine.
- the acid component and the alkali component are mixed with each other, they do not harden greatly and can form a uniform condyle. Omissions are also omitted.
- the acid component and the alkali component are kneaded separately in the conventional production of foaming failure; granulation, drying, and granulation are not performed. ': Must be sufficient
- the acid component and the alkali component can be mixed and then kneaded, granulated, dried and abducted, so that the production process is small.
- the tablet when the composition is a disintegrant, the tablet is not dissolved in water. When it sinks into I, it has II, the property required for effervescence.
- the failure hardness can be adjusted to about 2 to 15 kg.
- Disintegration time ' As the hardness increases, it becomes slow.
- a disintegrant can be adjusted to a foam state and the hardness can be adjusted to 24 kg or a large amount of foam can be generated and disintegrated within i minutes.
- the breaking time is 1 minute or longer:
- 10 tablets of vitamin C-containing effervescent tablets obtained by the method of the present invention are screwed and zipped together with silica gel. 0 months. Stored for 1 month, L color. Taste. Foaming state. No significant change in foaming time and content.
- the obtained mixture was dried in a vacuum dryer at 40 ° C. and 5 mmHg for 6 hours to produce expanded granules.
- the resulting colored and moistened sodium bicarbonate was dried in a vacuum dryer at 40 V, • 5 mmHg for 16 hours to produce a colored sodium bicarbonate- (3) obtained in (2) above.
- the resulting colored sodium bicarbonate (40 Og), saccharine sodium powder (40 g), and sodium benzoate (200 g) were mixed and sieved three times with a 32 mesh (JIS standard) sieve. 586 g of this and 5.0 000 g of the foamed granules obtained in the above (1) were put in a parchment / le granulator at a shop with a relative humidity of 50%, and the high speed (600 gram) was obtained. Rotate j ⁇ for 3 minutes at rpm) to mix.
- Foaming disintegrant obtained in this manner 0 suspicion; thickness; weight and hardness; foaming time when the tablet is dissolved in 100 ml of water under normal pressure, foaming state, pH Chop flavor is shown below c
- the resulting mixture was dried in an air drier at 40 and 5 Hg for 16 hours, and then was manufactured by Awayori.
- the obtained colored and humidified sodium bicarbonate was dried in a vacuum dryer at 40 ° C. and 5 mmHg for 16 hours to produce colored sodium bicarbonate.
- Storks B2 is used as a crushing machine, and ⁇ ⁇ temperature! ⁇ air (22%, relative humidity 10%) is blown around the crushing table of the tableting machine. s in which the relative humidity in the vicinity of the ⁇ %
- the rotation of the tablet presser is ⁇ 4 rotations Z minutes, and a 15 mm diameter corner circle is used.
- ORKaiNAl 2 Og of powdered lithium powder, 20 Og of sodium benzoate powder and 9 Og of perfume soda coat powder were mixed and sieved three times with a 32 mesh (JIS standard) sieve.
- 4 ⁇ lg of the two and the foamed condensate 500 g obtained in (1) above were placed in a vertical granulator in a room with a relative humidity of 50%, and at a high speed (600 rpm). Rotate the blades for 3 minutes and mix.
- the foaming time is 37 seconds.
- the following formulation F composition was used to produce a foamed tablet.
- Retame dressing 10 g, 5'-lactose powder 60 g and citrate anhydride 120 g were mixed and sprayed with 2 ml water.
- a mixture of 30 g of sport drink and 1 30 g of dihydrogen anhydride is mixed and sprayed with 3 ⁇ water.
- An effervescent tablet having the composition of the following formula I was produced according to the following method.
- a tableting machine (Kikusui Xo. 8F-3 tableting machine, manufactured by Kikusui Seisakusho, Japan) was used.
- the disintegration of the foaming disintegrant obtained in the above (2), thickness, weight and hardness, and disintegration of the disintegrant in 24 (: water of 10 Om: under normal pressure
- the foaming time, foaming state and soy taste in the case are shown below.
- an effervescent tablet having the composition of Formulation J is manufactured by the following method.
- Foamed tablets obtained in the form of 0, thickness, weight, weight, hardness, and hardness When the tablets are dissolved in water at 10 Omfi under normal pressure Foaming time, foaming state, PH foam The taste is shown below- One naive! i Thickness 1 Weight Hardness Foaming time Foaming; PH taste; j 1 ij
- composition of the present invention can be used as a pharmaceutical composition, a food composition, a pesticidal composition and a veterinary pharmaceutical composition that has a fast disintegration time and a rapid foaming.
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Nutrition Science (AREA)
- Food Science & Technology (AREA)
- Plant Pathology (AREA)
- Dentistry (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Environmental Sciences (AREA)
- Pest Control & Pesticides (AREA)
- Agronomy & Crop Science (AREA)
- Toxicology (AREA)
- Polymers & Plastics (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Preparation (AREA)
Abstract
In a process of producing a foaming composition by compounding a solid alkali metal carbonate (ingredient A), a solid aliphatic carboxylic acid (ingredient B), and an active ingredient (ingredient C), ingredient C is mixed with one or both of ingredients A and B, and the resulting two are respectively moistened with about 0.5 to 5% (w/w) water and mixed with each other. The foaming composition thus obtained disintegrates rapidly.
Description
明 細 書 Specification
発泡組成物の製造法 Method for producing foam composition
技術分野 Technical field
本発明は、 短時間で崩壌,発泡する優れた性質を有する発泡組成物に 関する- 背景技術 TECHNICAL FIELD The present invention relates to a foaming composition having excellent properties of breaking down and foaming in a short time.
発泡組成物の製造法としては、 種々知られてぃるが、 なかでも、 フラ ンス特許第 6 9 . 1 5 3 6 0号(公開番号第 2 , 0 4 4 .2 1 6号)および 米国特許第 3 , 7 7 3 , 9 2 2号公報が挙げられ、 これらにぉぃては、 少 量 水を用ぃて発泡成分でぁる炭酸化合物と酸化合物を加湿し、 最終的 に錠剤を得てぃる Various methods are known for producing foamed compositions. Among them, French Patent No. 69.1530 (published No. 2,044.216) and the United States Patent Nos. 3,773,922 are mentioned. In these, a small amount of water is used to humidify a carbonate compound and an acid compound as foaming components, and finally, tablets are prepared. Get
上記フラ ンス特許第 6 9 . 1 5 3 6 0号の方法にぉぃては、 塩基成分 粉 酸化合物)と酸成分の粉末とを別偃に水で加湿し混合し乾燥し ίニ後、 医薬成分を加ぇ、 打錠し、 発泡錠を製造してぃる- しかし がら、 該フランス特許の方法で;ょ、 加湿後の拉子:ょ微小なも 'となり、 ま 、 加湿乾燥後医薬成分を加ぇるので全体に占める粉末の 割合が多くなり、 打錠にさたっては、 ひっっき、 ぎしっき等打綻ェ程に ぉぃて、 種々 不都合を生じる。 また、 ぁまり粉末 '割合が多くなると ( 4 0 %以上 流動性が悪くなり、 打錠璣のホ パ—から混合粉末が流 ぃ為、 打錠不可能になる場合もぁる。 According to the method of the above-mentioned French Patent No. 69.15360, a base component (a powdery acid compound) and an acid component powder are humidified and mixed with water in a separate clam, dried, and dried. Pharmaceutical ingredients are heated and compressed to produce effervescent tablets-However, according to the method of the French patent; 、, humidified abalone: 微小 微小 と な り, and humidified and dried The addition of the components increases the proportion of powder in the whole powder, and causes various inconveniences in tableting, such as scratching and crushing. In addition, when the proportion of the “pulverized powder” increases, the fluidity becomes poor (over 40% or more), and the mixed powder flows from the hopper of the tableting machine, so that tableting may not be possible.
まに、 上記米国特許第 3 , 7 7 3 , 9 2 2号公報に記載の方法にぉぃて :ょ、 炭酸化合物,酸化合物ぉょび医薬成分を混合し造拉した後加湿し、 そ 後乾燥しっぃで打錠し、 発泡錠を製造してぃる3 In addition, according to the method described in the above-mentioned U.S. Pat. No. 3,773,922, a mixture of a carbonate compound, an acid compound and a pharmaceutical component is abducted, humidified, and then humidified. postdrying Shi'ide punch and tablets, Til 3 to produce effervescent tablets
しかしながら、 該米国特 ΐ午の方法で:ょ、 重炭酸ァルカリに対し 1 \ % 以下 水分を添加ォる でぁるが、 加ぇる医薬とクェン酸の量が重炭 酸ァルカリの量を越ぇるとき、 全重量に対する添加水分の量はフランス
特許の 0 . 5 %以下の水分添加と同じになり、 上記に記した如く、 微小 な粒子しかできなぃので、 打錠にぁたっては、 滑沢剤の効果が薄れ、 ひ っき、 ぎしっきの原因となる。 酸とァルカリの混合物に対して色々の量 の水を蒸気化して造粒させてぃるが特殊な装置が必要とされ一般的でな ぃ。 又水蒸気にょる加湿は、 水の添加にょる加湿と比铰し時間がかかり、 又吸湿量をコント σ ルォる は困難でぁる。 米国特許の実施例では重 炭酸ソーダを加湿後、 乾燦し 無水クェン酸を注入してぃるが、 無水ク ェン酸が、 その加湿された重炭酸ソーダにょって加湿されるまで無水ク ェン酸中での水分分布に差が出来ることにょ て生ずる反応が進んだと ころとそ όでなぃところでは差がぁり、 均 Κな混合物が得られにく い 発明の開示 However, in the United States special noon method: Alkali bicarbonate may be added with less than 1% water, but the amount of drug and citric acid added will exceed the amount of alkali potassium bicarbonate. When adding, the amount of water added to the total weight is France It is the same as the addition of water of 0.5% or less of the patent, and as described above, only fine particles can be formed, so in tableting, the effect of the lubricant is weakened, Cause Various amounts of water are vaporized and granulated for the mixture of acid and alkali, but special equipment is required and this is not common. Also, humidification with water vapor takes a longer time than humidification with the addition of water, and it is difficult to control the amount of moisture absorption. In the example of the US patent, sodium bicarbonate is humidified and then dried and infused with citric anhydride. However, anhydrous citric anhydride is humidified by the humidified sodium bicarbonate until it is humidified. DISCLOSURE OF THE INVENTION DISCLOSURE OF THE INVENTION DISCLOSURE OF THE INVENTION The reaction caused by the difference in the water distribution in the acid progressed and the difference was increased in other places, making it difficult to obtain a uniform mixture.
本発明者らは、 崩壌時間が早く、 速かに発泡し、 しかも製造が容易な 発泡組成物を製造すろ方法にっ .き、 κ意研 ¾ ところ、 炭酸化合物成 分ぉょび酸化合物 分 ー方 るぃ:ょ両方に ¾性成分を混合し、 両者を それぞれ約 0 . 5なぃし δ 水で加湿したのち混合するェ程を径るニ とにょり、 上記目的を満足す 発泡組成物を製造ォることができること を見ぃ出し、 さらに研究し ¾ ¾ 本発明を完成し : The present inventors have developed a method for producing a foamed composition that quickly breaks down, foams quickly, and is easy to produce. Separation method: Blend the active ingredient in both sides, humidify each with about 0.5 to 6 δ water, and mix them together. It has been found that the composition can be manufactured and further research has been made to complete the present invention:
本 明:ょ、 固体状の炭酸 ァ ^カリ金属塩 (" Λ成分バ以ド、 ァルカリ . 成分とぃぅこともぁる ΰ ;) .固体状 防族カルポン酸 (: B成分)〔以下、 酸成分とぃぅこと ぁる。 )ぉょび活性成分( C成分)を配合して発泡組 成物を製造する方法にぉぃて、 A成分ぉょび B成分 ー方ぁるぃ:ょ両方 に C成分を混合し、 両者をそれぞれ約 0 . 5なぃし 5 % ( w / w)の水で加 Sしたのち混合するこ とを特徵とする活性成分含肓発泡組成物 ^製造 ¾ の Akira Moto:. Yo, solid carbonate § ^ alkali metal salts (. "Lambda component Bas than de, Arukari that component and Iu Moaru Y;) solid proof Group Karupon acid (: B component) [hereinafter (Acid component) In the method of producing a foamed composition by blending the active ingredient (Component C), the A component and the B component are used. The active ingredient-containing foaming composition characterized by mixing the C component with both, adding each with about 0.5 to 5% (w / w) of water, and then mixing. of
本発明で用ぃられる炭酸のァルカリ金属塩としては、 とぇば炭酸ァ ルカ リ金属塩,重炭酸ァ カ リ金属塩,炭酸ァルカ リ土類金属塩などが挙 Examples of the alkali metal alkali carbonate used in the present invention include alkali metal carbonate, alkali metal bicarbonate, and earth alkali metal carbonate.
。
げられる。 . I can do it.
該ァルカ リ金属と しては、 たとぇばナ ト リ ゥム,カ リ ゥムなどが、 該 ァルカリ土類金属と してはたとぇばカルシゥム,マグネシゥムノくリ ゥム などが、 それぞれ挙げられる。 , 該炭酸のァルカリ金属塩の具体例として;ま、 たとぇば炭酸ナ ト リ ゥム, 炭酸カ リ ゥムなどが挙げられ、 なかでも炭酸ナ ト リ ゥムが最 好ま しぃ 該重炭酸ァルカ リ 金属塩の具体例と して:ま、 たとぇば重炭酸ナ ト リ ゥム, 重荧酸カ リ ゥムなどが挙げられ、 なかで 0重炭酸ナ ト リ ゥムが好ま しぃ = 該ァルカ リ土類金属塩の具体例と しては、 たとぇば炭酸カルシゥム,炭 酸マグネシゥム,炭酸バリ ゥムなどが挙げられ、 なかで 炭酸カルシゥ ムが好ま しぃ Examples of the alkali metal include, for example, sodium and calcium, and examples of the alkaline earth metal include calcium, magnesium and the like. . Specific examples of the alkali metal salt of carbonic acid include, for example, sodium carbonate and potassium carbonate, among which sodium carbonate is most preferred. as an example of Li metal salt: Also, other and Eba bicarbonate Na Application Benefits © beam, such as heavy荧酸mosquitoes Li © beam and the like, SHI = the preferred zero bicarbonate Na Application Benefits © beam in Naka Specific examples of alkaline earth metal salts include, for example, calcium carbonate, magnesium carbonate, and barium carbonate. Of these, calcium carbonate is preferred.
本発明で用ぃられる炭酸のァルカ リ金属塩としては、 上記した化合物 -.: '混合物で ょぃ The alkali metal carbonate of carbonic acid used in the present invention includes the above-mentioned compound-.
該荧酸 ァルカ リ金属塩':ま、 固体状 .'-バ用ぃられる 固体伏と し ては、 たとぇば扮末状,顆拉状 ;?、挙げられ、 なかでも、 顆拉状 のが 好ま しぃ The alkali metal salt of calcium sulfate: Solid is used in the form of a solid. I like it
穽明て闲ぃ れる ¾防族カルボン酸と して:-ょ、 ー塩基性 ' ,、 ニ 塩¾性 ' 、 三塩基性^も oなどが挙げられ , As the arresting carboxylic acid, there are:-basic, ', dihydrochloric', tribasic ^, o, etc.,
該ー塩基性脂昉族カルボン酸と しては、 たとぇ 水 S乍酸,グリ コ一ル 酸などが挙': f られる 該ニ塩基性脂防族カルボン酸と しては、 とぇば 酒石酸,フタ一ル酸,マレィ ン酸,マ σン酸,リ ンゴ酸,コハク酸などが挙 :ナ' れる 該三塩基性脂昉族カルボン酸としては、 たとぇば無水クェン 酸,クェン酸,ィソ クェン酸などが挙げられる。 Examples of the basic alicyclic carboxylic acid include water S-acid, glycolic acid, etc. Examples of the dibasic aliphatic carboxylic acid include: Examples of the tribasic aliphatic carboxylic acids include tartaric acid, phthalic acid, maleic acid, maleic acid, malic acid, ligonic acid, and succinic acid. , Isocyanic acid and the like.
脂防族カルボン酸は、 上記し 化合物の混合物でもょぃ。 脂昉族カル ボン酸としては、 なかで 無水クェン酸が最も好ま しぃ c The aliphatic carboxylic acid may be a mixture of the compounds described above. Among the aliphatic carboxylic acids, citrate anhydride is the most preferred. C
該固体状の脂防族カルボン酸と して':ま、 たとぇば粉末状のもの、 顆拉
状のものが挙げられ、 なかで 顆拉状のものが好ましぃ3 As the solid aliphatic carboxylic acid, ': Jo ones can be mentioned, I 3 Shi preferred those顆拉shaped in Naka
上記 A成分と B成分との比は、 約 1対 1 なぃし 〖対 2
が好まし 本発明の活性成分としては、 たとぇば医薬,食品.農薬.動物用薬など が挙げられる- 該医薬として: -ょ、 ニとぇばビタ ミ ン C (し—ァスコルビン酸, L - -ァス コルビン酸ナ 卜 リ ゥム, L ァスコルビン酸カルシゥム),パラァセ夕モ ール(ァセ 卜ァ ミ ノ フェン).ァスピリ ン(ァセチ;レサリチル酸),またはニ ら 組み合ゎせ、 ま は総合ビタ ミ ン剤成分:例、 ビタ ミ ン Α,Β ,. Ε3 ? . Β ;¾ , Β 5 , Β 0 , B 12. C,D .E ,葉酸,ミネラル(ί列、 鉄.カルシゥム.飼, カ リ ゥム,マグネシゥ厶.マンガン,亜鉛,ョー ド)など: どが挙げ れる: 医薬を 性成分として混合する場合の量として:ま、 発泡成分(Α成分 ぉょび Β成分:)に Wして約 .i 0 % (重量)以下 、好ま しぃつ The ratio of the A component and the B component is about 1: 1 The active ingredient of the present invention includes, for example, pharmaceuticals, foods, agricultural chemicals, veterinary medicines, etc.-The pharmaceuticals include:-,, and ぇ and vitamin C (ascorbic acid, L -Combination of sodium ascorbate, calcium ascorbate), paracetamol (acetominofen), aspirin (aceti; resalicylic acid), or a combination of two or more or comprehensive Vita Mi emission component:.?.. example, Vita Mi emissions Α, Β, Ε3 Β; ¾ , Β 5, Β 0, B 12 C, D .E, folic acid, minerals (I column, iron. Calcium breeding, california, magnesium, manganese, zinc, anode, etc .: Such as: When the medicine is mixed as a sexual component: The amount of the foaming component (Α component, ぉ component) :) to W, about .i 0% (weight) or less, preferably
該食品と して:ょ、 たとぇば粉末酒,ァスパ 'レテーム O— Lーァスパル チル - Lー フェニルァラニンメ チルェステル),ァセスルファム: 6 —メ チ レ— 1 .2.3—ォキサチァジンー 4— ( 3 Η )—ォンー 2.2—ジォキ サン . ;ょそ^カ リ ゥムなど ァルカ リ金属塩,サ ': /カリ ン,砂瑭等 b スボーッ ドリ ンケ等 ビ夕 ミ ンぉょびミ ネラル混^物,生薬油出物 を^む茶 どが挙げられる: The foods are as follows: 、, tobacco powdered wine, aspa'retam O-L-aspartyl-L-phenylalanine methylester, acesulfame: 6-methyl- 1.2.3-oxoxathiazine-4- (3 Η) ) —Wonder 2.2—Dioxan .; Alkali metal salt, such as potassium, sa :: carin, sand, etc. b Submarine mineral, etc. Teas containing crude oil extract include:
食品を活性成分として混合する場合の量としては、 発泡成分(A成分 ぉょび B成分)に対して約 6 () %(:重量)以下が好ましぃ When the food is mixed as an active ingredient, the amount is preferably about 6 ()% ( : weight) or less based on the foaming ingredient (A ingredient and B ingredient).
該農薬としては、 とぇばジべレリ ン酸などが举げ れる: Such pesticides include gibberellic acid and the like:
農薬を活性成分として混合する場合の量として 、 発泡成分(A成分 ぉょび B成分)に対し約 6 0 % (重量)以下が望ま しぃ- 該動物 ¾薬として:ょ、 とえばニ トロフラゾン,スルフ ァジメ トキシ ン .フラゾリ ドン .ク σルテ ト ラサィ クリ ンなどが挙げ 'られる - When the pesticide is mixed as an active ingredient, the amount is preferably not more than about 60% (weight) with respect to the foaming ingredient (A ingredient and B ingredient).-As the animal ¾ medicine, for example, nitrofurazone, Sulphadimethoxine, furazolidone, sigma lutetrasin, etc.
。
— D — . — D —
動物用薬を活性成分として混合する場合の量としては、 発泡成分(A 成分ぉょび B成分)に対し約 6 0 % (重量)以下が望ましぃ。 When the veterinary drug is mixed as the active ingredient, the amount is preferably less than about 60% (by weight) based on the foaming ingredients (component A and component B).
本発明の活性成分は、 粉末状のものでも、 顆粒化されたものでもょぃ。 なかでも、 顆粒化されたものが好ましぃ。 The active ingredient of the present invention may be in the form of powder or granulated. Among them, granulated ones are preferred.
活性成分の混合にっぃては、 塩基性の活性成分は、 荧酸のァルカリ金 属塩(A成分)と混合するのが好ましぃ。 酸性の活性成分は、 脂肪族カル ボン酸(B成分)と混合するのが好ましぃ。 中性の活性成分は、 A成分ぉ ょび B成分のどちらに混合してもょぃし、 ー方でもょぃ。 For the mixing of the active ingredients, the basic active ingredient is preferably mixed with the alkali metal salt of diacid (component A). Acidic active ingredients are preferably mixed with aliphatic carboxylic acids (component B). Neutral active ingredients can be mixed with either component A or component B, or both.
本発明の組成物の形状として:ま、 たとぇば錠剤,顆拉剤などが挙げら れる c The composition of the present invention may be in the form of, for example, a tablet:
本発明の発泡組成物の製造法を以下に記載する。 炭酸のァルカリ金属 塩( A成分)に、 必要にょり活性成分を混合し、 さらに必要にょり锆合剤 を混合し、 これを約 0 . 5なぃし 5 % (wZft 水で加湿する。 該桔合 剂の例と して 、 たとぇばポリ ビニルピ口 リ ドン,デキス ト リ ン,デキス トロース,乳糖,ァラビァゴム末,メチルセルロース,ヒ ドロキシプロ ピル チルセルロースなどが挙げられる = The method for producing the foam composition of the present invention is described below. The active ingredient is mixed as necessary with the alkali metal salt of carbonate (A component), and the mixture is further mixed with the mixture, and the mixture is humidified with about 0.5 to 5% (wZft water. as an example of桔合剂other and Eba poly Binirupi port Li pyrrolidone, dextrin Application Benefits down, dextrin Torosu, lactose, Arabiagomu powder, cellulose, human Dorokishipuro pills chill cellulose and the like =
1 ] I、:—)れる水の量としては、 さらに、 約 1 なぃし 3 %
が、 さら に約 1 いし 2 % (wZv が好ましぃ。 該水は、 所望にょり有璣溶媒を 添加し も を用ぃてもょぃ 該有機溶媒としては、 たとぇばェタノー ル,ァセ ト ンなどが挙げられる。 こ 場合、 水と有機溶媒との比率':ま、 約 1対 1 なぃし i対 4 (v/v)が好ましぃ。 1] I ,: The amount of water that is added is about 1 to 3% However, about 1 to 2% (wZv is preferred.) The water can be added with an organic solvent as desired. In this case, the ratio of water to the organic solvent is preferably about 1 to 1 but i to 4 (v / v).
また、 該水に、 着色料,甘味科などを添加し、 溶液としてぉぃてもょ L ' c 該着色料としては、 たとぇば、 リボフラビン,合成着色料たとぇば、 タ一トラジン,サンセッ トィェローなどが挙げられる c 該甘味料として は、 たとぇばサッカリ ン.ァスパルテ一ム,砂搪などが挙げられる c 加.湿する方法としては、 攪拌機中に入れ攪拌しながら水をスプレ一す
る方法,攪拌機中に入れ攪拌しながら少量ずっ水を滴下させる方法など が挙げられる。 In addition, a coloring agent, a sweetener and the like are added to the water, and the resulting coloring agent is, for example, riboflavin, a synthetic coloring agent, such as tatrazine, sunset, etc. C The sweetener includes, for example, saccharine aspartame, sand, and the like. C The wet method is to put water in a stirrer while stirring and spray. And a method in which a small amount of water is dropped while stirring in a stirrer.
固体状の脂肪族カルボン酸(B成分)に、 必要にょり活性成分を混合し、 さらに必要にょり桔合剤を混合し、 これを約 0 . 5なぃし 5 % (wZw)の 水で加 Sする。 The active ingredient is mixed as necessary with the solid aliphatic carboxylic acid (component B), and the mixing agent is further mixed as necessary, and the mixture is mixed with about 0.5 to 5% (wZw) water. Add S.
該锆合剤としては、 前記した Α成分の加湿ェ程にぉぃて用ぃられるも のと同様のものが挙げられる。 Examples of the composite include those similar to those used in the humidification of the above-mentioned components.
用ぃられる水の量としては、 さらに約 1なぃし 3 % (wZw)が、 さらに 約 I なぃし ·2 % (w/w)が好ましぃ。 The amount of water used is preferably about 1 to 3% (wZw), and more preferably about 1 to 2% (w / w).
該水は、 所望にょり有機溶媒を添加したものを用ぃてもょぃっ 該有璣 溶媒ぉょびその使用量として:ま、 前記した A成分の加湿ェ程にぉぃて用 ぃられる のと同様のもの,同様の使用量が挙げられる。 The water may be added with an organic solvent as desired, and may be used as the organic solvent and the amount of the organic solvent to be used: And the same amount used.
A成分ぉょび B成分をそれぞれ別個に加湿した後、 これらを混合する。 混合する方法として ':ま、 たとぇばバーチカルグラニュレ一ター(富士産 業侏式会社製,日本)等の攪拌機中で約 3〜 5分間混合する。 A component and B component are separately humidified and then mixed. As a mixing method, mix in a stirrer such as Tatoba Vertical Granulator (Fuji Industry Co., Ltd., Japan) for about 3 to 5 minutes.
上記混合,攪拌することにょり、 顆粒状のものが得られる。 邁常:ま、 ニ · ょぅにして得られた顆拉状のものを次のェ程に付されるが、 さらに 該顆拉を 8 メ ッ シュ(. J I S規格)の篩を通過し、 1 0 0メ 'ソ シ ュ(J I S規¾) 篩を通過しなぃ大きさの のとするのが好ましい。 By mixing and stirring, a granular product is obtained. Suzuki: Well, the condyla-like shape obtained in the first step is attached to the following procedure, and the condyla is further passed through an 8-mesh (.JIS standard) sieve. It is preferable that the size be such that it does not pass through a 100-mesh (JIS standard) sieve.
このょ όにして得られた顆拉:ま、 乾燥ェ程に付される- 該乾燥の方法 としては、 たとぇば真空乾燥機中で約 4 0 ° (:〜 6 0て.約 0〜 5 mmH g , 約 8〜 1 6時間乾燥する、 通風乾燥機中で約 4 0〜 6 0 約 1 ~ 3時 間乾燥する、 などが挙げられる。 The condyla obtained in this manner is then subjected to a drying process. The drying method is, for example, about 40 ° in a vacuum drier (: about 60 °. 5 mmHg, drying for about 8 to 16 hours, drying for about 40 to 60 in a ventilation dryer for about 1 to 3 hours, and the like.
打綻用顆拉の製造の際に、 酸成分ぉょびァルカリ成分を含有する発泡 顆拉に、 滑沢剤を焙散としたものを加ぇてもょぃ。 これは、 滑沢剤をそ のまま発泡顆粒と混合すると静電気にょり球形の大拉の頼拉になる傾向
がぁる ©で、 滑沢剤をたとぇばァルカリ成分ぁるぃ:ま酸成分と混合し篩 過することにょり、 滑沢剤の顆拉化を防ぎ滑沢剤の効果をょく する こと ができ、 そのため打綻を容易に行なぅ ことができる。 又、 別途顆拉化さ れた炭酸のァルカリ金属塩を加ぇることにょって、 得られた錠剤の発泡 カを増強することができる。 In the production of condyles for crushing, a foamed condensate containing an acid component and an alkali component may be added with a roasted lubricant. This is because if the lubricant is mixed with the foamed granules as it is, it will tend to become a gallant gallary with static electricity When the lubricating agent is used, it is mixed with the acid component and sieved to prevent the lubricating agent from abrasion and reduce the effect of the lubricating agent. Therefore, the failure can be easily performed. Further, the foaming power of the obtained tablet can be enhanced by adding the alkali metal salt of carbonic acid which has been separately ablated.
このようにして得られる乾燦された頼拉を錠剤にォるには、 該顆拉を 打錠する。 打錠に際して:ょ、 顆拉に、 所望にょり、 着色料,呑料, ·味枓 調味料 .結合剂 .圧縮潤滑剤などを添加したのち、 打錠ェ程に付して ょ I.、 , In order to put the dried sunflower obtained in this manner into a tablet, the tablet is compressed. At the time of tableting: After adding colorants, drinks, flavor seasonings, binding agents, compression lubricants, etc. to the tablets, add them to the tableting process as desired. ,
上記着色料として;ま、 たとぇばリ ボフラビン,夕ー トラジン,サンセッ トィェ C7—などが挙げられる 上記香钭と しては、 たとぇばォレン ジォ ィ .'レ,レモンォィ;レ,ォレ ンジパゥダ一,レ乇ンパゥダーなどが孥 i f :っ ή ろ: tr味钭としては、 とぇばサ ,カ " ン,ァス 儿'テ一ム,砂瑭な どカ、^げられる。 上記調味钭と しては、 ^とぇばグル夕 ミ ン酸ソ一ダ, 该酸調味料,コハク酸,粉末カッすダシなどが举げられ : Examples of the coloring agent include riboboflavin, evening trazine, sunset C7, and the like. Examples of the above-mentioned flavors include, but are not limited to, lemony; lemony; For example, if the zipper or the rainpad is not used, it can be used as a flavor, such as tobasa, kan, ass tem, sand, etc. Examples of these include ^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^ s \ s And t either times long times either, it is sodium glutamate, 该 acid seasoning, succinic acid, and powdered ash.
Jニ記活性成分が農薬で る場 、 ゾ-ニとぇは:乳化^など仝忝勺ロし、 錠剤 と して よぃっ 該乳化剂 :'例と して 、 ラゥ リ ル硫酸十 ト リ ゥム,ホ J When the active ingredient is an agricultural chemical, zoni and: are emulsified, etc. 仝 仝 仝 仝 仝 剂 該 剂 '' '' '' Realm, ho
- ビニ .'しピ リ ドン .ホ リェチレ ングリ コ一;レ.多([Hiァ—'レコー 'レ . ' ij旨^酸ェ スチル とぇばス ン(ソルビタ ン^昉酸ェスチ , A t l as Powd er Co . ti 製,米国),ッ ィ一ン ポリォキシェチレンソルビタ ン》脂防酸ェステ レ, A t i as Powder Co .社製),砂饍ェス ルなどが挙; ら る--ニ ピ ピ リ ピ ピ ピ ピ ピ ビ ビ [ビ--ビ ぇ ェ ぇ-------------------旨 旨---旨as Powder Co. ti, United States), di-polypolyxethylene sorbitan, fatty acid-resistant ester, Ati as Powder Co., Ltd.), sand sand, etc .; -
.ヒ記活性成分が動物 薬でぁろ場合、 とぇば乳化剖 どを添加し、 綻剂と して ょぃ- 該乳化剤 ^と しては、 ラゥ リ ル硫酸ナ ト リ ゥム, ボリ ビニルビロ リ ドン,ポリェチレ ングリ コール .多 ffiァ;レコ一ルの I]旨防 酸ェステル, とぇ スパン,ッ ί —ン,砂瑭ェス千ルなどが挙: f られる 打錠の際に ¾い れる结合剤と して':ょ、 とぇばポリ ビニルピ G リ ド If the active ingredient is a veterinary drug, add emulsifier, etc., as a failure. The emulsifier ^ is sodium laurylsulfate, boric acid. Vinyl virolidone, polyethylene glycol. Polyester; alcohol-proofing ester; polyester, spandex, sandstone, etc .: For tableting. As a mixture to be used:
βΑ ORIGINAL
ン.デキス ト リ ン.ァラビァゴム扮末,メチルセルロース.ヒ ドロキシブロ ピルメチルセルロース,砂耱などが挙げられる。 βΑ ORIGINAL N.dextrin.arabia gum, methylcellulose.hydroxypropylmethylcellulose, sandstone, etc.
打綻の際に用ぃられる圧縮潤滑剤としては、 たとぇばステァリン酸ナ ト リ ゥム,安息香酸ナ ト リ ゥム,ポリェチレングリ コール 4 0 0 0 ,ポリ ェチレングリコール 6 0 0 0などが挙げられる c Compression lubricants used in the event of failure include, for example, sodium stearate, sodium benzoate, polyethylene glycol 400, polyethylene glycol 600, and the like. C
打綻は、 自体公 ¾の通常用ぃられる方法にょり行なゎれる - このょぅにして得られた発泡組成物にぉぃて、 活性成分が医薬でるる 場合、 有効投与量となる量の医薬を含有する組成物をたとぇば次 ょ ό にして人に投与する。 The breakdown can be carried out according to the method generally used in the public domain itself-in the foamed composition obtained in this way, if the active ingredient is a medicament, the effective dose For example, the composition containing the above drug is administered to a human.
ロの中に入れ発泡溶解ぁるぃ;ょ懸'蜀後、 砍み込 t、ことにょり轻ロ投与ォ る。 Put in the foam and dissolve the foam;
水 -に人れ発泡させ溶液ぁるぃは懸蜀液とし、 ニれを経ロ投与する; 水に入れ発泡させ溶液ぁる L、は懸蜀液としこ . を皮膚;こ塗布し医薬を径 皮投与する。 Apply water to the skin and apply the solution to the skin; apply the solution to the skin; apply the solution to the skin; apply the solution to the skin. Administer dermally.
浴槽 % {:入れ発泡溶解ぁるぃ:ょ懸蜀さ仕入浴し皮膚から医薬を吸収さ る Bath tub% {: Put foaming dissolving solution: Take a bath and absorb medicine from skin
锭剂 ^場合:よ膣内に投与し発泡溶解ぁるぃは懸凝さ i± S薬を吸収さ仕る . 锭 剂 ^ If: yo vaginal dissolving effervescent dissolving i ± S drug absorption.
¾体的には、 たとぇば、 ァスコルビン酸を 1錠 Φ約 5 0 0 - 1 0 0 0 含 fTする本発明の発泡綻 1 〜 2綻を水約 6 0〜 2 0 ϋ m iに人 発泡溶 解させ、 これを钦む。 More specifically, for example, one tablet of ascorbic acid contains about 500 to 100 000 fT. Dissolve and dissolve.
本発明方法にょって得られに発泡組成物にぉぃて、 活性成分が食品で ぁろ場合、 有効摂取量となる量の食品を含有する組成物をたとぇば次 ょ όにして使用する When the active ingredient is obtained as a food from the foamed composition obtained by the method of the present invention, a composition containing an amount of the food to be an effective intake is used, for example, in the following manner.
人 ロの中に入れ発泡溶解ぁるぃ':ょ懸阖後钦み込む Bubble dissolution in a person
水に入れ発泡させ溶液ぁるぃは懸蜀液としこれを人が飲 The solution is foamed in water and the solution is made into a suspension.
調理中にその讨科に入れるぁるぃはふ かける。
組成物が顆粒でぁる場合、 洗った野菜にこれをふりかける。 - 具体的には、 たとぇば、 生薬抽出物を含む茶を 1綻中約 5 0 0〜 1 0Sprinkle the pulps into the family during cooking. If the composition comes in granules, sprinkle it on the washed vegetables. -Specifically, for example, tea containing crude drug extract is about 500 to 10
0 0 mg含有する本発明の発泡錠 1 〜 2錠を 4 0 ° 〜 8 0て 湯約 6 0〜0 to 80 mg of the effervescent tablet of the present invention containing 100 mg to 40 ° to 80 °
1 0 0 m lに入れ発泡溶解させ、 これを飲む。 , 本発明方法にょって得られた発泡組成物が農薬でぁる場合、 有効撒布 置となる 農薬を含む祖成物は、 とぇば、 該組成物を水に入 ¾泡 さ仕溶液 るぃ:ょ懸蜀液としこ を対象生物に撒布すろ- 木発明方法にょって得られた 泡組成物にぉぃて、 活性成分が動物 ¾ 镇て όる場合、 有効投与鼂となる鼂 動物 ffl薬を含有する組成物 ^ と ぇば次 ょ にして投与する: Put into 100 ml to dissolve foam and drink. When the foamed composition obtained according to the method of the present invention is a pesticide, the artificial substance containing the pesticide which is to be an effective spraying device is, in most cases, the composition is put into water and foamed.ぃ: Sprinkle the suspension solution and mushrooms on the target organism.-In the foam composition obtained by the method of wood invention, if the active ingredient is an animal, it becomes an effective administration. Animal ffl The composition containing the drug is administered as follows:
水に人れ発泡さ ti-、 溶液あるぃは懸籣液とし、 これを動物に飲ま t_ト . 水に 発泡させ、 溶液 るぃ(ょ懸阇液とし、 これを動物にスブレ一ォ 水 i 、 ; κに入 発泡さ辻、 溶解 ろぃ:ょ懸 ;せ、 そ 中で動物を水浴 ό让る When the water is ti-foamed in the water, the solution is used as a suspension, and this is drunk by the animal. The water is foamed in the water, and the solution is suspended in the water. i,; Enter κ Foamed Tsuji, Dissolve Filter: Suspended;
本¾ ^ 0的物: .:' ¾泡組成物が顆泣 場合、 該顆粒:ょ、 截扮が少 く V■■■ くささ 7)、揃-、てぃる で、 ス ト リ Vプ包装しゃォく、 又ス 卜 リ ヅフ. ii¾ ' -, 'レム接 H部に微粉がっぃて接着不良を起ニォとぃうょぅ ニ とが い, したが .て、 該顆泣は、 そ '取极ぃが容 ¾でぁる s ¾ 0 顆 的.. '............................... 場合 場合 場合.. 顆 顆 When the foam composition crys, the granules: Ii¾ '-', 'REM contact' There is a fine powder on the H part, causing poor adhesion. is, its' To极Igayo ¾ Dearu s
さらに、 該顆拉:ょ、 大さく揃 た顆拉でぁリ、 水に投入し 場合、 底 に¾んだ後良好に発泡ォる- 卞発明方法にぉぃて、 ¾泡組成物が顆泣で 5る を製造する場 、 使 ¾ォる水が少鼂な .で乾燦が容易て'ぁる。 また、 めらされた酸成分 とァルカリ成分とを混合すると、 大きく固まらず、 均一な顆拉ができる で、 通常^顆¾製造ェ程に必要とされる乾噪ェ程前 製粒ェ程を省略 オるニとがでさる さらに、 該顆拉:ょ、 乾燥後、 拉同志はぁまりひっっ In addition, the condyla: a large uniform condyle, when poured into water, is well foamed after filling into the bottom. According to the Bybyn invention method, the foam composition is condensed. In the place where you can make 5 pieces by crying, you can use a little water and it is easy to shine. Also, when the acid component and the alkali component are mixed with each other, they do not harden greatly and can form a uniform condyle. Omissions are also omitted.
BAD OF ei鼠
ぃてぃなぃので篩過するだけで簡単に整拉できる。 したがって、 該顆泣 のェ業的生産は容易でぁる s BAD OF ei rat It is easy to abduct simply by sieving. Therefore, E industry production of the condylar crying easily Dearu s
本発明方法にぉぃて、 発泡組成物が錠剤でぁるものを製造する場合、 従来の発泡綻の製造では酸成分とァルカリ成分を别々に練合.造粒.乾燥, 製粒しな':十ればならなぃカ 本発明方法では酸成分とァルカリ成分とを 混合してから練合,造粒.乾墚,製拉することができるので、 製造ェ程钕 が少なくてォむ According to the method of the present invention, when the foamed composition is produced in the form of a tablet, the acid component and the alkali component are kneaded separately in the conventional production of foaming failure; granulation, drying, and granulation are not performed. ': Must be sufficient In the method of the present invention, the acid component and the alkali component can be mixed and then kneaded, granulated, dried and abducted, so that the production process is small.
本発明方法で得られ ^顆拉:ょ、 微粉が少なぃので、 錠剤の製造時には 滑沢剤の使 ¾量が少なくて済み、 打錠性が良ぃ 3 また、 該顆粒は微粉が 少なぃので、 打錠の際 ひっっき .ぎしっきを防ぐことができる。 Obtained in the present invention a method ^顆拉: Yo, since fines less Nai, requires less use ¾ amount of lubricants in the production of tablets, compressibility is Yoi 3 also granule fine powder less Nai Because of this, it is possible to prevent scratching during tableting.
本発明の発泡組成物にぉぃて、 該組成物が綻剤でぁる場合、 該錠剂:ょ、 水中にぉ ':ナる崩壌時間か早く、 水中にぁって:ま長く水底に沈んでぃると I、ぅ発泡綻に要求される性質を II備してぃ With respect to the foamed composition of the present invention, when the composition is a disintegrant, the tablet is not dissolved in water. When it sinks into I, it has II, the property required for effervescence.
本発明方法にょると、 綻剂 硬度を約 2 〜 1 5 kgぐらぃ迄調節するニ とか 'できる。 崩壊時間':ょ硬度が大きくなると遅くなるので用途に t、じて 崩壞時問の調節 L可能となる According to the method of the present invention, the failure hardness can be adjusted to about 2 to 15 kg. Disintegration time ': As the hardness increases, it becomes slow.
本 明方法にょると、 綻剤 ½泡状態 調節可能て、 硬度を 2 4 kg にォると钿かぃ大量 泡が発生し i 分以内に崩壊ォ 硬度を 5 kg以.ヒ にォ と泡が大きくなり、 壊時間も 1 分以上に る: 靱中に、 本発明 方法で得 れた 1 0錠のビタ ミ ン C含有発泡錠をシリカゲ.'レと共にネジ キャ,ゾプをして 6 0て. 1 カ月保存して L色.味.発泡状態 .発泡時間,含 量に大きな変化はなぃ で、 本発明方法で得 れ ビ夕 ミ ン 有発泡 錠:ょ、 室温では少なく と b 2 〜 3年は安定と思ゎれる- 特にビ夕 ミ ン C は変色しゃすぃ性質を持ってぉり、 煞,水分に対して不安定で るが、 該綻剤中では安定でぁる = According to the method of the present invention, a disintegrant can be adjusted to a foam state and the hardness can be adjusted to 24 kg or a large amount of foam can be generated and disintegrated within i minutes. And the breaking time is 1 minute or longer: In the tongue, 10 tablets of vitamin C-containing effervescent tablets obtained by the method of the present invention are screwed and zipped together with silica gel. 0 months. Stored for 1 month, L color. Taste. Foaming state. No significant change in foaming time and content. The foamed tablet obtained by the method of the present invention: at least b at room temperature. It is expected to be stable for 2 to 3 years-especially Biminin C has a discoloration property and is unstable to water and moisture, but is stable in the disintegrant =
発明を実施するための最良の形態
次に実施例をもって本発明をさ らに具体的に説明する c なぉ、 パ一セ o 5 BEST MODE FOR CARRYING OUT THE INVENTION Then examples have been c Nao specifically explaining the present invention is al, Pas one cell o 5
ン ト:ま、 と く にことゎりのなぃかぎり、 を示す。 Comment: Well, unless otherwise noted.
実沲例 1 Example 1
次の処方 Aの組成を有する発泡錠剤を製造した. An effervescent tablet having the following formulation A was produced.
処方 Λ Prescription Λ
注 i C - 9 7 515.5mgf ヒタ ン として 500mg) it 2 無水クェン酸 300 mg Note i C-9 7 515.5 mgf 500 mg as titanium) it 2 300 mg of citric anhydride
注 3 重炭酸ナ 卜 リ ゥム 550 mg Note 3 sodium bicarbonate 550 mg
サッカ リ ン十 卜 リ 'ウ 10 mg Saccharin 10 mg
0 安息香酸ナ 卜 リ ゥム 50 mg 0 sodium benzoate 50 mg
計 1,425.5mgC 1 錠中) 1,425.5mgC in 1 tablet)
注 1 : C - 9 7 : H 特公昭 5 8 4 0 :3号公報 実施例 1 に記載 Note 1: C-97 : H Japanese Patent Publication No. 5840: 3 Publication No.
:' 方 で製造し广丄 ァスコルビン酸 9 7
ぉょひコ ーン ス夕一壬 3 ¾ ' 仝含む顆 : 以下の実施例 2〜 4 b 同 : 'Manufactured by Guangdong Ascorbic acid 9 7 ひ コ 一 一 仝 顆 顆 顆 顆 顆
/ 11 無水クェン酸;ょ、 4 0 メ シュ J I S規 f各 .篩も 1過する / 11 Cuic anhydride; 40 mesh J IS f Each sieve also passes
頼拉を ¾い Λ: 以下 -.:' '¾ ¾例 2〜 8 ί 様: Laira Λ Λ : Below-.: '' ¾ ¾Example 2 ~ 8 ί
ΐ 3 炭酸ナ ト リ ゥム: J:、 I 0 メ 'ソ シ ュ J I S ¾格 j 蒒を通過 ΐ 3 Carbonate sodium: J :, passed through the I0 method JIS qualification j
ォる顆 ¾ 印い 以 ト ノ ¾¾例 2 - 8 同様 顆 顆 顆 以
製造法 Manufacturing method
': υ 黄色 5 (sし nset yei low) 5 gを水に溶かし、 i O O mi 着色水と し 茧炭酸ナ ト り 厶 に 8 kgをバーチカル · グラニュレーターに入 、 高速(6 0 ϋ rpnUで 根を 5分間回転させた後、 上記着色水 〖 8 mi を少量ずっ加ぇなが 、 5分間回転させた。 别途、 C - 9 7 2 . 0 6 2 kgと無水ウェン酸粉末 1 . 2 kgとをバ一チカル · グラニュ レ一ターに 入れ.、 高速(6 0 ϋ rpm:)て羽根を 5分間回転さ辻 後、 上記着色水 3 3 ': Υ Dissolve 5 g of yellow 5 (s and nset yei low) in water, and use it as colored water. 8 Add 8 kg of sodium carbonate to the vertical granulator and use high speed (60 ϋ rpnU). After the roots were rotated for 5 minutes, a small amount of the above-mentioned colored water (8 mi) was added, and then the mixture was rotated for 5 minutes. kg into a vertical granulator. Rotate the blades at high speed (60ϋ rpm :) for 5 minutes.
BAB ORIGINAL
mlを少量ずっ加ぇながら 5分間回転させた。 これに、 上記で得た着色し 加湿された重炭酸ナトリゥムを加ぇ、 3分間混合した。 BAB ORIGINAL The solution was rotated for 5 minutes while adding a small amount of ml. The colored and humidified sodium bicarbonate obtained above was heated and mixed for 3 minutes.
得られた混合物を、 真空乾燥機中で、 4 0 °C.5mmHgで I 6時間乾燥 し、 発泡顆粒を製造した。 The obtained mixture was dried in a vacuum dryer at 40 ° C. and 5 mmHg for 6 hours to produce expanded granules.
(2) 重炭酸ナトリゥム i kgをバーチカル · グラニュレーターに入れ、 高 速(6 0 0 rpm)で羽根を 5分間回転させた後、 上記 0)で得られたのと同 様の着色水 I 0 mlを少量ずっ加ぇながら、 5分間回転させた。 (2) Place sodium bicarbonate i kg in a vertical granulator, rotate the blades at high speed (600 rpm) for 5 minutes, and then use the same colored water I 0 as obtained in 0) above. The solution was rotated for 5 minutes while adding a small amount of ml.
得られた着色し加湿された重炭酸ナトリゥムを真空乾燥璣中で 4 0 V, •5 mmHgで 1 6時間乾燥し、 着色重炭酸ナトリ ゥムを製造した- (3) 上記(2)で得られた着色重炭酸ナトリ ゥム 4 0 Og,サッカリ ンナト リゥム粉末 4 0g,安息香酸ナトリゥム扮末 2 0 0 gを混合し、 3 2メ ッ シュ( J I S規格)の篩で 3回篩過した- この内の 5 8 6 gと、 上記(1)で 得られた発泡顆粒 5.0 0 0 gとを関係湿度 ·5 0 %の郞屋でパ—チカ /レ · グラニュレーターに入れ高速(6 0 0 rpm)で j拫を 3分間回転させ混合 し / "ニ。 The resulting colored and moistened sodium bicarbonate was dried in a vacuum dryer at 40 V, • 5 mmHg for 16 hours to produce a colored sodium bicarbonate- (3) obtained in (2) above. The resulting colored sodium bicarbonate (40 Og), saccharine sodium powder (40 g), and sodium benzoate (200 g) were mixed and sieved three times with a 32 mesh (JIS standard) sieve. 586 g of this and 5.0 000 g of the foamed granules obtained in the above (1) were put in a parchment / le granulator at a shop with a relative humidity of 50%, and the high speed (600 gram) was obtained. Rotate j 拫 for 3 minutes at rpm) to mix.
(:4) 打錠機としてス トークス B 2 (F.J. STOKES CORPORATIO 製,米国)を 用ぃ、 打錠機の打綻テ一ブル周辺に眩湿度の圧カ空気(2 2て.関係湿度 1 () %)を吹き込み、 忤臼の付近 関係湿度を〖 0 %とした。 打錠機の 回耘数を 1 4回¾/分とし、 1 5匪直径 隅: 仵を闭ぃ、 上記(3)で得 られ 混合物を打綻した。 ( : 4) Stokes B 2 (made by FJ STOKES CORPORATIO, USA) was used as a tableting machine. The compressed air with dazzling humidity (2. )%), And the relative humidity in the vicinity of the mortar was reduced to 0%. The number of tills of the tableting machine was set to 14 times / min, and the diameter of the band of 15 bands was changed to 闭 ぃ. The mixture obtained in the above (3) was broken.
このょぅにして得られ 発泡綻剤; 0直怪 .厚み.重量ぉょび硬度,錠剤 を 2 4て 0水 1 0 0 mlに常圧下に溶解した場合の発泡時間,発泡状態, p Hぉょび味を以下に示す c Foaming disintegrant obtained in this manner; 0 suspicion; thickness; weight and hardness; foaming time when the tablet is dissolved in 100 ml of water under normal pressure, foaming state, pH Chop flavor is shown below c
,'
直 径 學 み 硬 度:発泡時間 泡状態 PH 味 , ' Diameter study Hardness: Foaming time Foam state PH taste
- 5 - Five
• (mm) (mm) (g) (kg) ' ; ; ; • (mm) (mm) (g) (kg) ';;;
• 15.10 6.01 1.457 5 ; 1分 20秒: 良好 5.62 甘ぃ . • 15.10 6.01 1.457 5; 1 minute 20 seconds: good 5.62 sweet.
実沲例 2 Example 2
次 ¾方 13の組成を有する発泡錠剤を製造した , Next, an effervescent tablet having the composition of Method 13 was produced,
処方 B Prescription B
C - 9 7 515.5mg (ビタ ン Cと して 500mg) 無水クェン酸 4 0 mg C-97 515.5 mg (500 mg as C) Cyanic anhydride 40 mg
0 盧炭酸ナ ト リ ゥム 525 mg 0 sodium carbonate 525 mg
サヅカ リ ン十 ト リ ゥム 7.5mg Saccharin 10 Trim 7.5mg
吞料サィダ一コ一 卜 ン 22.5mg Food 2.5%
50 mg 50 mg
If 1 , 570. omg' 1 錠中) If 1, 570. omg 'in 1 tablet)
製造 ¾ Manufacturing ¾
' .½色 Γ)号'、 sunset yellow) 5 gを水に溶か.し、 1 0 0 ηιΙΛ着色水と '.½ Γ)', sunset yellow) Dissolve 5 g in water and add 100 ηιΙΛ
¾¾酸+ト '! ゥム 1 . 5 kgをバーチカル ' ゲラニュ レ一 一に入 ':.、 s¾ii 6 0 0 rpm)て羽根を 5 »間回 さ让 後、 上, ¾1涛色水 1 5 nil 少 ¾ォ 'っ加ぇながら、 5分間回耘さ仕 っ 別途、 C - 9 7 2. 0 6 2 kgと無 、 ェン酸 1 . 8 kgとをパ一チカル · グラニュレ一タ一に人れ、 髙速 6 0 0 rpmノで羽根を 5分間回 ¾さ仕た後、 ヒ記着色水 3 8 mlを少 ¾fっ加ぇながら 5分間回転させた: これに、 上記で得た着色し加湿さ れ 炎酸十 ト リ ゥ厶を加ぇ、 3分閻混 ^した ¾¾acid + to '! . © beam 1 to 5 kg 'entering the Geranyu Les eleven' vertical:., S ¾ii 6 0 0 rpm) after 5 »Makai is让wings Te, on, ¾1涛色water 1 5 nil small ¾ O ' Separately, add C-977.2062 kg and 1.8 kg of phosphoric acid to a vertical granulator and add speed. After spinning the blades at 600 rpm for 5 minutes, it was rotated for 5 minutes while adding 38 ml of colored water in a small amount of water: the colored and humidified flame obtained above. Heated with acid 10 minutes, mixed for 3 minutes
得ふれ 混' 物を、 ¾空乾燥機中で、 4 0て, 5關 Hgで 1 6時間乾噪 し、 泡頼拉^製造し / . The resulting mixture was dried in an air drier at 40 and 5 Hg for 16 hours, and then was manufactured by Awayori.
(2') 重炭酸ナ 卜 リ ゥム 1 kgをバ一チカル · グラニュ レー夕一に入れ、 高 (2 ') Add 1 kg of sodium bicarbonate to the vertical granule
BA© oniGlNAlp
BA © oniGlNAlp
221 ο 速(6 0 O rpm)で羽根を 5分間回転させた後、 上記(1)で得られたのと同 様の着色水 1 0 mlを少量ずっ加ぇながら、 5分間回転させた。 After rotating the blade at 221 ο speed (60 O rpm) for 5 minutes, the blade was rotated for 5 minutes while adding a small amount of 10 ml of the same colored water as obtained in (1) above.
得られた着色し加湿された重炭酸ナトリゥムを真空乾燥機中で 4 0 °C, 5mmHgで 1 6時間乾燥し、 着色重炭酸ナトリ ゥムを製造した。 The obtained colored and humidified sodium bicarbonate was dried in a vacuum dryer at 40 ° C. and 5 mmHg for 16 hours to produce colored sodium bicarbonate.
δ (3) 上記(2)で得られた着色重炭酸ナトリ ゥム 6 0 0 g,サ'ソカリ ンナ ト リゥム粉末 3 0 安息番酸ナトリゥム粉末 2 0 0 g,香料サィダ一コート ン扮末 9 0gを混合し、 3 2メ 'ソ シュ( J I S規格)の篩で 3回篩過した c この内の 9 2 0 gと、 上記(1)で得られた発泡顆拉 δ 0 0 0 gとを関係湿 度 5 0 %の部屋でパーチカル · グラニュレータ一に入れ高速( 6 0 0 rpm)δ (3) Colored sodium bicarbonate 600 g obtained in the above (2), sasocarina sodium powder 30 0 sodium benzoate sodium powder 200 g, fragrance sodium powder 9 0 g was mixed and sieved three times with a 32 Mesh (JIS standard) sieve c. Among them, 920 g of the foamed condensate obtained in (1) above and Relationship humidity 50% in a room with a vertical granulator put at high speed (600 rpm)
10 で羽根を 3分間回転させ混合し ニ。 Rotate the blade for 3 minutes with 10 and mix.
(4) 打綻機としてスト一クス B 2を用ぃ、 打錠機の打綻テーブル周辺に ί氐温度の! Ξカ空気(2 2て,関係湿度 1 0 %)を吹き込み、 忤臼の付近の 関係湿度を〖 ϋ %とした s (4) Storks B2 is used as a crushing machine, and ί 氐 temperature! Ξ air (22%, relative humidity 10%) is blown around the crushing table of the tableting machine. s in which the relative humidity in the vicinity of the 〖ϋ%
打錠獰の回転欵を〖 4回転 Z分とし、 1 5mm直径の隅丸忤を用ぃ、 上 The rotation of the tablet presser is 〖4 rotations Z minutes, and a 15 mm diameter corner circle is used.
15 記(3)で得られ 混合物を打錠し 15 Tablet the mixture obtained in (3) above
ニ、 ょ όにして得られた発泡綻剤の直 ί圣,厚み.重量ぉょぴ硬度,錠剤 ^ 2 4て 水 1 0 0 miに常!!下に溶解した場合 発泡時間,発泡状態. ·· H .味 .直 ί圣,厚みぉょび重量を以下に ォ .、 D, thickness, weight and hardness of the foaming disintegrant obtained in the above procedure, tablets ^ 24 and water always at 100 mi! When dissolved below, foaming time, foaming state, H taste, straightness, thickness and weight are as follows.
直 ίΐ 厚 み 重 量 硬 度:発泡時間発泡状態 ΡΗ 味 (mm) . (nun) (g) : (kg) - 15.15 6.11 1.60 7 1分 10秒 良好 . 4.77 ゃゃ酸 Straight Thickness Weight Hardness: Foaming time Foaming state Taste (mm). (Nun) (g): (kg)-15.15 6.11 1.60 7 1 minute 10 seconds Good. 4.77 Acidic acid
: 味ぁり 実施例 3 . : Taste Example 3.
次の処方 Cの組成を有する発泡錠剤を製造し Γ Produce effervescent tablets having the following formulation C:
処方 C
C - 9 7 515.5mg〔ビタ ンじとして 500mg) fl Prescription C C-9 7 515.5mg (500mg as a button) fl
無水クェン酸 450 mg Cyanic anhydride 450 mg
重炭酸ナトリ ゥム 500 mg Sodium bicarbonate 500 mg
サッカ リ ンナ ト リ ゥム 5 mg Saccharin sodium 5 mg
香料サィダ一コートン 22.5mg 22.5mg perfume cider one carton
安息香酸ナ トリゥム 50 mg Sodium benzoate 50 mg
計 1,543 mg( l錠中') Total 1,543 mg (in 1 tablet)
製造法 Manufacturing method
(1) 黄色 5号(sunset yellow) 5 gを水に溶かし、 1 0 0ml 着色水と (1) Dissolve 5 g of sunset yellow 5 in water and add 100 ml of colored water
0 し ίΖ 0 ίΖ
重 酸ナトリゥム 1 . 8 kgを'くーチカル♦ グラニュレーターに入れ、 高速 6 0 O rpm)で羽拫を 5分間回転させた後、 上記着色水 1 8 mlを少 量^っ加ぇな 、 5分問回 させ尸ニ 1.8 kg of sodium bicarbonate is put into a ♦ -granular ニ ュ granulator, and the blade is rotated at a high speed of 60 O rpm) for 5 minutes. Then, a small amount of 18 ml of the above colored water is added. Divide the question
途、 C— 9 7 2. 0 6 2 kgと無水グェ 酸粉末に 8 kgとをバー チカル · グラニュ レーターに入れ、 高速( 6 0 0 rpm)て羽根を δ分間回 させ 後、 上記着色水 3 2 mlを少量ずっ ¾ぇなか δ分間回転させた。 i .〖こ、 上記て得た着色し加湿され 崁酸十トリゥム 加ぇ、 3分間 得ふ 混 物を、 真空幸 燥機中で、 4 ()て:, 5 mmHgで 1 6時間乾燥 し、 発泡顆粒を製造した In the process, put 2 kg of C-97.26.02 kg and 8 kg in anhydrous genoic acid powder into a vertical granulator, rotate the blade at high speed (600 rpm) for δ minutes, and then A small amount of 2 ml was spun for δ minutes. i. Pico, heated with colored and humidified 10% nitric acid obtained above, dried for 3 minutes in a vacuum desiccator, and dried at 5 mmHg for 16 hours. Manufactured foam granules
〔2) 重炭酸ナ 卜リゥ厶 1 kgをバ一チカ ,'レ♦ ゲラニュレーターに入れ、 高 ii i 6 0 0 rpm)で羽根を 5分間回耘させ 後、 上記 で得られ と同 様 着色水 1 () mlを少量ずっ加ぇながら、 5分間回転させた (2) Put 1 kg of sodium bicarbonate into a banana, レ ラ ラ ラ ラ ラ ラ ラ ラ ゲ ラ 、 、 高 高 回 高 高 高 高 高 5 5 Spin for 5 minutes while adding a little (1) ml of colored water
得:0 - T 着色し加湿され 重炭酸ナト リゥムを真空乾燥璣中で 4 0 X , 5 mmHgで 1 6時 Ρ 乾璨し、 着色重炭酸ナトリゥムを製造し ί Obtained: 0 -T colored and humidified sodium bicarbonate dried in vacuum at 40 X, 5 mmHg for 16 hours to produce colored sodium bicarbonate.
(3) 上記(2)で得られ /"こ着色重炭酸ナ 卜リゥム 2 0 0 g,サッカリ ンナト (3) Obtained in (2) above / "This colored bicarbonate sodium 200 g, saccharin nato
ΒΆΒ ORKaiNAl
リゥム粉末 2 O g,安息香酸ナトリゥム粉末 2 0 O g.香料サィダーコート . ン粉末 9 O gを混合し、 3 2メ ッ シュ( J I S規 )の篩で 3回篩過した。 ニの内の 4 δ l gと、 上記(1)で得られた発泡顆拉 5 0 0 O gとを関係湿 度 5 0 %の部屋でバーチカル · グラニュレーターに入れ高速(6 0 0 rpm) で羽根を 3分間回転させ混合し†ΒΆΒ ORKaiNAl 2 Og of powdered lithium powder, 20 Og of sodium benzoate powder and 9 Og of perfume soda coat powder were mixed and sieved three times with a 32 mesh (JIS standard) sieve. 4 δ lg of the two and the foamed condensate 500 g obtained in (1) above were placed in a vertical granulator in a room with a relative humidity of 50%, and at a high speed (600 rpm). Rotate the blades for 3 minutes and mix.
) 打錠璣としてス トークス B 2を用ぃ、 打錠機の打錠テ一ブル周辺に 眩 「复 ',「£カ空気(2 2 =C.関係 S度 1 0 %)を吹き込み、 忤臼 付近 関係;显度を 1 0 %とし Γ 打錠璣の回転数を 1 4回耘 /分とし、 1 5 mm 直 S 隅丸忤を ぃ、 上記(3)で得られた混合物を打綻した ) Stokes B2 was used as a tableting machine, and dazzling “「 ”,“ £ カ air (2 2 = C. related S degree 10%) was blown around the tableting table of the tableting machine. Relationship around the mortar; 显 tableting at 10%, 4tableting 璣 at 14 times / min, 15 mm straight S corner round ぃ, breaking the mixture obtained in (3) above did
ニ ί)ょぅにして得られ 発泡錠剤の直径.學み,重量ぉょび硬度,锭剂 ^ 2 4て 水 1 ϋ ϋ mlに常圧下に溶解した場合の発泡時間,発泡状態, PH ,味を以下に示ォ.: D) The diameter of the effervescent tablet obtained by studying. Weight, hardness and hardness, effervescence time when dissolved in 1ϋ ϋ ml of water under normal pressure, effervescent state, PH, The taste is shown below:
直 径 . み 電 量 硬 度 発泡時 ίΠ]免泡伏態: ρΗ 味 Direct diameter. Coulomb hardness When foamed.] Foam free: ρΗ Taste
(aim) ; (m) (g) (kg) (aim) ; (m) (g) (kg)
5.12 6.12 1.569 し分 25秒 良好 ■ 4.66 酸味ぁり 5.12 6.12 1.569 min 25 seconds good ■ 4.66 sour
次 ¾i D 組成を有ォる発泡锭剂を製造し C 9 7 247 mg (ビク ミ Cと 240mg) ァスビリ ン遨紬粉 400 mg Next, produce foam with iD composition.C 9 7 247 mg (240 mg with Vicumi C)
-' ェン酸 1,200 mg -'Cic acid 1,200 mg
® 酸十トリゥム 1,800 mg ® Acid 10 Trim 1,800 mg
ボリェチレンゲリ コール 6000 20 mg Voljechlengelicol 6000 20 mg
サ ':;カリ ン十 ト リ ゥム 10 mg Sa ':; 10 mg of carinum 10 mg
安息香酸ナ 卜 リ ゥム 100 mg Sodium benzoate 100 mg
BA0 ORIGINAL
計 3,777 mg( 1錠中) - 製造法 BA0 ORIGINAL Total 3,777 mg (per tablet)-Manufacturing method
(1) 重炭酸ナトリゥム 1 . 8 kgをバーチカル · グラニュレーターに入れ 高速(6 0 0 rpm)で羽根を 5分間回転させた後、 水 2 O mlを少量ずっ加 ぇながら 5分間回転させた。 (1) 1.8 kg of sodium bicarbonate was placed in a vertical granulator, and the blades were rotated at a high speed (600 rpm) for 5 minutes. Then, the mixture was rotated for 5 minutes while adding a small amount of 2 O ml of water.
(2) 别途、 C — 9 7 2 4 7 g,ァスピリ ン微钿扮末 4 0 0 g,無水クェン 酸 1 , 2 0 0 g,ポリェチレングリ コール粉末 2 0 gをバ一チカル · グラニュ レーターに入れ高速( 6 0 0 rpm)で羽根を 5分間回転させた後、 水 2 0 mlを少量ずっ加ぇながら 5分間回 fcさせた- 加 Sした重炭酸ナトリゥ厶 を加ぇ 3分間混合し / (2) Application: C—972 47 g, aspirin fine powder 400 g, citrate anhydride 1, 200 g, polyethylene glycol powder 20 g were added to a vertical granulator. After rotating the blades at high speed (600 rpm) for 5 minutes, the mixture was fc-turned for 5 minutes while adding a small amount of 20 ml of water. The sodium bicarbonate added was mixed for 3 minutes.
( 上記(2)て得られた混台物を真空乾燥璣中て . 6時間(4 0て, 5 Hg)乾燥し η,. (The mixed product obtained in (2) above was dried in a vacuum dryer for .6 hours (40 and 5 Hg), and η ,.
U 乾燥後 混合物を 3 2 メ ·;/ ンュ篩過しそ -. ぅち 3 . 5 kgをとりサッ カリ ンナ トリゥム粉末 9 . 3 g¾び安息香酸+トりゥム扮末 9 3 gを加ぇ てバーチカル · ゲラニュ レーク一に入れ高速( 6 0 0 rpm)で羽根を 3分 問回耘さ辻混合し - 混合物を直 S 2 5mm 平面仵を用ぃて直 S約 2 5 Him み約 6匪 1錠当り 重量 3 8 0 0 mg '綻剂をっく : 1 6 V. 水 1 0 O niiに常圧下で溶解した場 ^ '発泡時間: i: I分 1 5沙てぁ た: U After drying, the mixture was sieved through a 32 2-mesh / mushroom sieve. Take 3.5 kg and add 9.3 g of Saccharinna Trim Powder and add 9.3 g of benzoic acid + Trim. Into the vertical gerany lake and mix the wings at high speed (600 rpm) for 3 minutes.-Mix the mixture directly using a flat surface of S2 5 mm. Weight per tablet: 3800 mg 'Disintegration: 16 V. Dissolved in 10 O Nii under normal pressure ^' Foaming time: i: I min.
' . m 5 '. m 5
次 ΰ処方 組成を有ォる発泡錠剤を製 し 。 Next, a foamed tablet having the following prescription composition was produced.
¾方 Ε ¾
注 1 扮 *酒♦ ァルコ 'ゾ 1.000 mg * 1 Dress * Sake ♦ Arco'zo 1.000 mg
無水クェン酸 1,000 mg Cuic anhydride 1,000 mg
重荧酸ナ卜リゥム 1,000 mg Sodium bicarbonate 1,000 mg
安息香酸ナ卜リ ゥム LQO mg Sodium benzoate LQO mg
!1- 3, 100 mg( 1綻中)
注 1 : 粉末酒 · ァルコック 日本特公昭 4 7— 3 9 3 5 5号公報参照! 1- 3, 100 mg (1 in progress) Note 1: Powdered liquor · Arkok See Japanese Patent Publication No. 47-393355
,ゥォ 'ソカタィプ,ァルコール分 3 0. 5 w/w% , '' ソ カ タ カ タ カ タ, コ ー ル コ ー ル 30.5 w / w%
製造法 Manufacturing method
(1) クェン酸 1 0 Ogと粉末酒ァルコック 1 0 Ogを混合し 3 mlの水をス プレ一した。 (1) 10 Og of cunic acid and 10 Og of powdered Alcohol were mixed and sprayed with 3 ml of water.
(2) 別途重炭酸ナトリゥム 1 0 0 gに 1 m の水をスプレ一し/"ニ: (2) Separately spray 1 m of water on 100 g of sodium bicarbonate / "D:
(3) )¾び(2)で得られ ΰのを混合後通風乾燥機中で 5 0 V 2時間 乾燥した- (3) After mixing the ΰ obtained in ¾ and (2), the mixture was dried in a ventilation dryer at 50 V for 2 hours.
(4) 乾璨後の混合物 2 5 0 gと安息番酸ナトリゥム扮末 8. 1 gとを混合 し、 直径 2 () mm 平面忤を用ぃて直 ί圣約 2 0顏厚み約 7睡 1錠当り 直(4) 250 g of the mixture after drying and 8.1 g of sodium benzoate were mixed, and the diameter was about 20 (7) sleep using a 2 () mm flat face. Straight per tablet
S3. I g ,硬度 5 kgの錠剤をっく ったっ 2 0 Vの水 S3. Tablets with a hardness of 5 kg and hardness of 20 kg
1 0 0 miに常「£下で溶解し 場合 発泡時間は 3 7秒でぁっ When dissolving at 100 mi, the foaming time is 37 seconds.
寞施例 6 Lonely example 6
次 処方 F 組成を すろ発泡錠剤を製造した。 The following formulation F composition was used to produce a foamed tablet.
¾方 F Fou F
ァス ':ルテーム(甘味料) 100 mg As': Luteme (sweetener) 100 mg
,5 - ラク 卜ース 600 mg , 5-lactose 600 mg
ウ ェン酸 1.200 mg - Uric acid 1.200 mg-
¾炭酸十トリ ゥム 1,000 mg ト リ Carbonate 10 1,000 1,000 mg
—— _H^±J:」 ク 45 mg —— _H ^ ± J: ”45 mg
If 2.945 tng( 1錠当り) 製造法 If 2.945 tng (per tablet)
(1) ァスパ)レテーム扮末 1 0 g, ,5' -ラク トース粉末 6 0 g¾び無水クェ ン酸 1 2 0 g 混合し 2 ml 水をスプレ一したっ (1) Aspa) Retame dressing 10 g,, 5'-lactose powder 60 g and citrate anhydride 120 g were mixed and sprayed with 2 ml water.
(.2 別途重炭酸ナ卜リ ゥム 1 0 0 に 1 miの水をスプレーし Γ (.2 Separately spray 1 mi of water on sodium bicarbonate 100
(;3) (:1 Sび(2)で得られ ニ のを混合後通風乾燥機中で 5 0て, 2時間 (; 3) (1) After the mixture obtained in 1S and (2) is mixed, the mixture is placed in a draft dryer for 50 hours and
姆
乾燥した。 Mummy Dried.
(4) 乾燥後の混合物 2 5 O gと安息香酸ナトリゥム粉末 3 . 9 gとを混合 し直怪 2 O mmの平面杵を用ぃて直径 2 0 . 1 5 mm,厚み 7 . 1 1 ,重量 3 Og,硬度 4 . 7 kgの錠剤をっく った。 2 5 Cの水 1 0 0 miに常圧下で溶 解した場合の ¾泡時間は 2分 1 5秒でぁった 2 (4) Mix 25 Og of the dried mixture and 3.9 g of sodium benzoate powder, and use a straight punch of 2 Omm to make a 20.15 mm diameter, 7.11 mm thick. I wrote a tablet weighing 3 Og and hardness 4.7 kg. 2 5 C ¾ bubbles time when you dissolve under normal pressure in water 1 0 0 mi of Atta 2 in 2 minutes 1 5 seconds
実沲例 7 Example 7
次 処方 Gの組成を有ォる ¾泡錠剂を製造しに: Next To make a “foam tablet” with the composition of formula G:
処方 G Prescription G
注 i スポ一ッ ドリ ンク 夕ケダ し 300 mg Note i Spot drink evening cut 300 mg
無永 ェン酸 し 300 mg Nonaganoic acid 300 mg
重炭酸ナ 卜 リ ゥ厶 500 mg Bicarbonate sodium 500 mg
— 1羞壁 ^ mg — 1 shaven ^ mg
計 3. :'15 mg( i綻当り) Total 3.: '15 mg (per i failure)
ill : スポ一ッ ドリ ン クタ ケダ: ビ夕 ミ ノ · ミ ネラ ル混合ソフ ト ド リ ン ク。 スポ一ッ ド:! ン ク 1 3 g中-卩記ビク ミ ン ' ミ ネラルを 含 ォろ - ビ夕 ミ ン C 500mg, ナ ィァ シ ン i g, リ ン酸 4'3mg. ビク ミ 0.8mg, ·+- ト リ 丄、 ϋθίίΐί, マ ゲネシ 厶 4nig, ビ夕 ミ ン132 1. lmg, カ リ ゥム 7Smg, ケ 一 .'t 106mg 製造法 ill: Spot drinker Ked: Mixed soft / drink mineral drink. Sports :! Ink 13 g / -Bikmin 'Mineral containing minerals-Bimin Min C 500 mg, Nyacin ig, phosphoric acid 4'3 mg.Bikumi 0.8 mg,丄, ϋθίίΐί, magnesium 4 nig , bismuth 13 2 1.lmg, calcium 7Smg, ke.'t 106mg
(1) スポ―ッ ドリ ンク夕ケゲ扮末 i 3 0 g,無水ゥェン酸 1 3 0 gを混合 し 3 πι 水をスプレー し (1) A mixture of 30 g of sport drink and 1 30 g of dihydrogen anhydride is mixed and sprayed with 3πι water.
(2) 別途重炭酸ナ 卜リゥム 5 0 gに水 i mlをスブレ一し (2) Separately spray iml of water on 50 g of sodium bicarbonate.
(3) (1)¾び'、2)で得られ も 'を混合後通風乾墚櫟中で 5 0て, 2時間 乾璨し - (3) After mixing (1) Ebi 'and 2),' 'is mixed and then dried for 50 hours in air-dried lime and dried for 2 hours-
(:4) 乾'噪後 '混合物 3 0 0 gと安息香酸ナトリ ム粉末 4 . 3 gを混合し (: 4) Dry After mixing 300 g of the mixture and 4.3 g of sodium benzoate powder
^ ORfGflSfAL
直怪 2 0 mmの平面忤を用ぃて直怪 2 0 . 〖 2 mm,厚み 7 . 4 l mm,重量 3 . 1 5 g,硬度 6 . 5 kgの锭剤をっく った。 2 5 °Cの水 1 0 0mlに常 下で 溶解した場合の発泡時間は 1分〖 0沙でぁった。 ^ ORfGflSfAL Using a 20-mm flat-screen plaque, a patch of 20.2 mm in thickness, 7.4 lmm in thickness, 3.15 g in weight, and 6.5 kg in hardness was prepared. When dissolved in 100 ml of water at 25 ° C under normal conditions, the foaming time was 1 minute.
実施例 8 Example 8
次の処方 Hの組成を有する発泡錠剂を製造した。 An effervescent tablet 有 す る having the following formulation H was produced.
処方 H Prescription H
注 1 Lete Kindertee(.\'est le' Alete GmbH) 1,400 mg Note 1 Lete Kindertee (. \ 'Est le' Alete GmbH) 1,400 mg
(ァレテキンダーテー ネッスルァレテゲーェムべーハー社製,ス ίス) 無水クェン酸 700 mg (Altekindate Nessle Altegembecher Co., Ltd., base) 700 mg of anhydrous citrate
重炭酸ナトリ ゥム 700 mg Sodium bicarbonate 700 mg
安息番酸ナトリ ゥム 45 mg Sodium benzoate 45 mg
- 計 2,845 mg( 1錠当 ) 注 1 : ァレ キングーテ一 -Total 2,845 mg (per tablet) * 1
スィス.ネッスルァレテゲ一ェムべー '、一社製の茴香,ジャ ス ミ ン, U"草,カ ミ レ .ァニス,/1ちじゃ ニ そ .メ リ ッサ, '、 'ソカ, S. Nessularetegembe ', a single company's Fenja, Jasmin, U "Grass, Camileanis, / 1 Chija Nis. Melissa,', 'Soca,
^水ハ '·/カ 値物抽出物を含む顆拉化 3 : 茶 ^ Condensation with water extract / mosquito extract 3: Tea
製造 ¾ Manufacturing ¾
Π) -',レテキンダーテー(顆粒) 1 4 O gと無水ケェン狻 7 () g , 合し 2 πιし:'水をスブレーした: Π)-', Retekindate (granules) 14 O g and anhydrous 狻 7 () g, combined 2 πι:'
(2) 别途 M ' ζ酸ナ 卜 リ ゥム 7 0 gに 1 1 水をスプレ一しに: (2) Application M 'acid sodium water 70 g to spray 1 1 water:
(_1)¾び(2:)で得られ/ 1 を混合後通風乾璨機中で 5 0て.2時間 乾璨した: (_1) Obtained in crab (2:) / 1 was mixed and dried in a ventilator for 50 to 0.2 hours:
(4) 乾燥後 G混合物 2 5 0 gと安息香酸ナトリゥム扮末 4 . 0 gを混合し 直¾ 2 0 甲-面仵を ¾ぃて直径 2 0. 1 9 mm,厚み 6 . 5 3 fflm,S量 2 . 8 5 g ,硬度 1 1 kg 錠剤をっく っ ^: 5 0て Λ水 6 0 m 1に常 E下で溶解 し 場合 発泡時間は 5 0秒で った。 (4) After drying, 250 g of the G mixture and 4.0 g of sodium benzoate were mixed, and the mixture was directly exposed on the instep to obtain a diameter of 20.19 mm and a thickness of 6.53 fflm. , S content 2.85 g, hardness 11 kg Tablet: ^: 50 and dissolved in 60 ml of cold water under normal E. The foaming time was 50 seconds.
BA© ORfGI!Kf
実施例 9 BA © ORfGI! Kf Example 9
次の処方の Iの組成を有する発泡錠を下記の方法にょり製造した < 処方 I An effervescent tablet having the composition of the following formula I was produced according to the following method.
Lーァスコルビン酸 300 mg L-ascorbic acid 300 mg
S A - 9 9 (注) 795.4 mg (ビ夕 ン Cとして 700mg) 無水クェン酸 950 mg S A-9 9 (Note) 795.4 mg (700 mg as bisphenol C) Cyanic anhydride 950 mg
重炭酸ナト リ ゥム 950 mg Sodium bicarbonate 950 mg
無水乳耱 574.6 mg Anhydrous milk 耱 574.6 mg
フマ— .)レ酸 250 mg Fuma 250 mg
サ 'ソカ リ ンナ ト リ ゥム 20 mg Sokalin natrium 20 mg
ァス ルテーム 10 mg Asluteme 10 mg
昏钭サィダーコ— ト ン 100 mg Coma Cider Cotton 100 mg
計 3,950 mg ( 1錠当 Total 3,950 mg (1 tablet equivalent
(? t> S A - 9 9:特開昭 5 7 - 5 9 8 0 3号、 実験例 1に記載の—流動造 拉法にょる頼拉 製造法—にし がって製造したァスコルビン酸ナ 卜 リ ムぉょびコ— ンス夕 —チ i % ( '.' ')を含む顆粒-. ) 黄色 5号(sunset yel
gを水に溶かし、 l O O ml 着色水と し Ϊ 重荧酸ナ ト リ ゥム 9 5 O gをパ—チカル ♦ グラニュ レータ ーに人 れ、 高速(6 0 ϋ ι·ρηι)で羽拫を 5分間回転させた後、 上記着色水 3 O ml ^少量ずっ加ぇなから、 5分間回 させ、 S A - - 9 9 7 95. 4 gを加 ぇ 1 0分間回転後、 サン 卜ーズ K 3 7 4 . 6 g加ぇ 5分間回転し混合し ト n (? T> SA-99: Ascorbic acid sodium produced according to the experimental method 1 described in Japanese Patent Application Laid-Open No. 57-58903, Experimental Example 1顆粒 び 顆粒 顆粒-granules containing i% ('.'')- Dissolve g in water, make lOO ml of colored water, and use sodium hydrogen peroxide 95 5 Og as a participant. ♦ Take the granulator to a high speed (60 0ι · ρηι). Rotate for 5 minutes, then add 3 O ml of the above colored water ^ small amount, then rotate for 5 minutes, add SA--997 95.4 g 回 転 Rotate for 10 minutes, K 3 7 4. 6 g pressurized tut rotated 5 minutes mixing preparative n
得られ 混合物を真空乾璨璣中で、 4 0 =C δ mniHgで 1 6時^乾噪し、 発泡顆粒を製造し 。 The resulting mixture was dried in a vacuum oven at 40 = CδmniHg for 16 o'clock to produce expanded granules.
C2) サン ト一ズ K 2 0 0 g,フマール酸 2 5 0 g,サッカ リ ンナ ト リ ゥム
粉末 2 Og, ァスパルテーム I 0g及び香料サィダーコー ト ン 1 0 0gを . 混合し 6 0メ 'ソ シ ュ( J I S規格)の篩で篩過した。 C2) Santos K 200 g, fumaric acid 250 g, saccharin sodium 2 Og of powder, 0 g of aspartame I and 100 g of perfume soda coat were mixed and sieved with a 60-mesh (JIS standard) sieve.
この内の 5 1 6gと、 上記(1)で得られた発泡顆粒 3 , 0 0 Ogとを関係湿 度 5 0 %の部屋でバーチカル♦ グラニュレーターに入れ高速(6 00 rpm) で羽根を 3分間回耘させ混合した。 Of these, 5 16 g and 3, 000 Og of the foamed granules obtained in (1) above were placed in a vertical ♦ granulator in a room with a relative humidity of 50%, and the blades were crushed at high speed (600 rpm). It was cultivated for a minute and mixed.
(3) 打錠機(菊水 Xo. 8 F - 3打錠機,菊水製作所製, 日本)を用ぃ、 そ の回転数を 1 4回耘ノ分とし、 2 3 mm直怪の普通面忤を用ぃ、 上記(2) で得られた発泡綻剤の直怪,厚み、 重量ぉょび硬度ならびに該綻剤を 2 4=(:の水 1 0 Om:に常圧下に溶寸解した場合の発泡時間,発泡状態,ΡΗぉ ょび味を以下に示す。 (3) A tableting machine (Kikusui Xo. 8F-3 tableting machine, manufactured by Kikusui Seisakusho, Japan) was used. The disintegration of the foaming disintegrant obtained in the above (2), thickness, weight and hardness, and disintegration of the disintegrant in 24 = (: water of 10 Om: under normal pressure The foaming time, foaming state and soy taste in the case are shown below.
直径 厚み 重量 ' 硬度 '発泡時間 .発泡 :味 Diameter Thickness Weight 'Hardness' Foaming time. Foaming: taste
乂 mnu (mm) • (g) ' (kg) 状態 , 乂 mnu (mm) • (g) '(kg) condition,
•23.15 ' 8.2 :1分38秒 良好 -4.52 甘ぃ ' 実施例 1 0 • 23.15 '8.2: Good for 1 minute and 38 seconds -4.52 Sweetener' Example 10
次 処方 Jの組成を有ォる発泡錠を下記の方法にょり製造し っ Next, an effervescent tablet having the composition of Formulation J is manufactured by the following method.
処方 B Prescription B
C τ 9 7 309.3rag (ビ夕 ミ ン Cと して 300mg) C τ 9 7 309.3rag (300 mg as Vimin C)
S A - 9 9 795.4mg (ビタ ミ ンじとして 700mg) 無水クェン酸 950 mg S A-9 9 795.4 mg (700 mg as vitamin) Cyanic anhydride 950 mg
重炭酸十 ト リ ゥム 950 mg Bicarbonate 10% 950 mg
サン ト一ズ 525.3mg Sun's 525.3mg
フマール酸 250 mg Fumaric acid 250 mg
サッカリ ンナ ト リ ゥム 20 mg Saccharinum sodium 20 mg
香料サィダーコー ト ン 100 mg Perfume Sider Coat 100 mg
3,900 mg (1綻当たり)
製造法 3,900 mg (per break) Manufacturing method
(1) 黄色 5号(s nset yel low) 5 gを水に溶かし、 1 0 Οπιβの着色水とし た。 重炭酸ナトリゥム 9 5 Ogをバ一チカル . グラニュレーターに入 れ、 高速(6 0 O rpm)で羽根を 5分間回転させた後、 上記着色水 2 δ mfi を少量ずっ加ぇながら、 5分間回転させ、 S A - 9 9 7 9 5.4gを加 ぇ 1 0分間回転後,サントーズ K 3 2 5.3 gを别途、 C— 9 7 3 0 9.3 gと無水クェン酸 9 δ 0 gをバ一チカル♦ グラニュレータ一に入れ、 高速(6 0 0 rpm)で羽根を 5分間回転させた後、 上記着色水 2 Omi!を少 量ずっ加ぇながら 5分間回転させた = (1) 5 g of yellow No. 5 (snset yellow low) was dissolved in water to obtain 10 1πιβ colored water. 95 Bg of sodium bicarbonate was put into a vertical granulator, and the blades were rotated at a high speed (60 O rpm) for 5 minutes. Then, the mixture was rotated for 5 minutes while adding a small amount of the above colored water 2δmfi. Then, add 5.4 g of SA-9779 and rotate it for 10 minutes, then apply 5.3 g of Santo's K3, 9.3 g of C-9703 and 9δ0 g of citric anhydride in a vertical manner ♦ placed in a granulator and foremost, after rotating the blades 5 minutes at high speed (6 0 0 rpm), rotated the colored water 2 Omi! a small amount Zu' pressurized tut with 5 minutes =
これに上記で得 着色し加湿された重炭酸ナトリゥム, S A- 9 9 ,サン トーズ Κ混合物を加ぇ、 3分間混合し/ "ニ。 To this, add the colored and humidified sodium bicarbonate, SA-99, Suntoose mixture obtained above and mix for 3 minutes.
¾られ /·ニ混合物を真空乾'噪璣中で、 0 =C 5關 Hgで 1 6時間乾噪し、 ¾泡顆拉を製造し The mixture was dried in a vacuum oven at 0 = C5 related Hg for 16 hours to produce the foam.
(:2) サン ト一ズ K 2 0 () g ,フ マ一ル酸 2 δ 0 g,サッカ リ ンナ ト リ ゥム 粉末 2 () g¾び番科サィダーコ一 ト ン 1 0 ϋ gを混合し 6 0メ .ゾ シ ュ (J I S規格、:■->篩で 3回篩過し/^ こ 内の 5 1 4 gと、 上 ( 1 )で得ら - . ¾泡頸拉 3.0 0 0 gとも関係湿度 5 0 ¾でパ一チカル. · ゲラ ニュ し ータ一に人れ高速(6 0 O rpm')で羽根を 3 ¾回¾さ辻混^し (3)打錠褛(菊水.\'0.8 F - 3菊水製作所製.日本' iを ¾ぃ、 そ '回 数を 1 4回転. 分とし、 2 3關直怪 普通面忤を用ぃ、 上記(2)で得られた 混合物を打錠した。 (: 2) Santozu K 20 () g, fumaric acid 2 δ 0 g, saccharin natrium powder 2 () g 60 Mesh (JIS standard: ■-> sieve through sieve three times / ^ 5 14 g in this, and obtained in (1) above. Also related to g. Humidity is 50 ° C. Participants are in the same condition. · The blades are mixed 3 times at high speed (60 O rpm '). (3) Tableting (Kikusui . \ '0.8 F-3 manufactured by Kikusui Seisakusho. Japan "i" is ¾ ぃ, the number of times is 14 rotations. Min. The mixture was compressed.
ニ ょぅにして得られた発泡錠剤 0直怪,厚み.重量ぉょび硬度 らびに 詨錠剤を 2 7て 水 1 0 Omfiに常圧下に溶解した場合 発泡時間,発泡 状態, P Hぉょび味を以下に示ォ -'
1直怪 ! i 厚み 1 重量 硬度 発泡時間 発泡; PH 味 ; j 1 i j Foamed tablets obtained in the form of 0, thickness, weight, weight, hardness, and hardness When the tablets are dissolved in water at 10 Omfi under normal pressure Foaming time, foaming state, PH foam The taste is shown below- One naive! i Thickness 1 Weight Hardness Foaming time Foaming; PH taste; j 1 ij
! (mm) j (mm) j (g) ί (Kg) 状態! ! (mm) j (mm) j (g) ί (Kg) condition!
! !
: 23.15 ! 8.421 3.89S 10.9 1分 20秒 良好 .: 4.45 甘ぃ i : 23.15! 8.421 3.89S 10.9 1 minute 20 seconds Good.: 4.45
産業上の利用可能性 Industrial applicability
本発明の組成物は、 崩壌時間が早く、 速ゃかに発泡する医薬組成物, 食品組成物,農薬組成物 .動物用薬組成物として利用できる: =
The composition of the present invention can be used as a pharmaceutical composition, a food composition, a pesticidal composition and a veterinary pharmaceutical composition that has a fast disintegration time and a rapid foaming.
Claims
- 25 - 請 求 の 範 囲 - 固体状の炭酸のァルカリ金属塩(A成分),固体状の脂肪族カルボン酸(B 成分)ぉょび活性成分(C成分)を配合して発泡組成物を製造する方法に ぉぃて、 A成分ぉょび B成分の一方ぁるぃは両方に C成分を混合し、 両 者をそれぞれ約 0 . 5なぃし 5 の水で加湿したのち混合するこ とを特徴とォる活性成分含有発泡組成物の製造法
-25-Scope of the request-A foamed composition is prepared by blending a solid alkali metal salt of carbonic acid (component A), a solid aliphatic carboxylic acid (component B) and an active component (component C). According to the manufacturing method, A component and one component of B component are mixed with C component, both are humidified with about 0.5 to 5 water, and then mixed. PROCESS FOR PRODUCING FOAM COMPOSITION CONTAINING ACTIVE COMPONENT
Priority Applications (13)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
PCT/JP1985/000625 WO1987003002A1 (en) | 1985-11-08 | 1985-11-08 | Process for producing foaming composition |
JP61009809A JPS61183219A (en) | 1985-02-07 | 1986-01-20 | Production of foamable composition |
AU52909/86A AU590537B2 (en) | 1985-02-07 | 1986-01-31 | Method for producing foamable compositions |
EP86101330A EP0190689B1 (en) | 1985-02-07 | 1986-02-01 | Method for producing foaming composition |
DE8686101330T DE3687317T2 (en) | 1985-02-07 | 1986-02-01 | METHOD FOR PRODUCING BREWING MIXTURES. |
AT86101330T ATE83652T1 (en) | 1985-02-07 | 1986-02-01 | PROCESS FOR THE MANUFACTURE OF Effervescent Mixtures. |
DK053086A DK169140B1 (en) | 1985-02-07 | 1986-02-04 | Process for the preparation of foaming compositions |
NZ215054A NZ215054A (en) | 1985-02-07 | 1986-02-05 | Method for producing foaming (effervescent) compositions |
CA000501177A CA1272132A (en) | 1985-02-07 | 1986-02-05 | Method for producing foaming composition |
EG63/86A EG17932A (en) | 1985-02-07 | 1986-02-06 | Method for producing foaming composition |
ES551698A ES8800038A1 (en) | 1985-02-07 | 1986-02-06 | Method for producing foaming composition. |
FI860566A FI86799C (en) | 1985-02-07 | 1986-02-07 | Process for making foamable mixtures |
US07/282,989 US4897257A (en) | 1985-02-07 | 1988-12-02 | Method for producing foamable composition |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
PCT/JP1985/000625 WO1987003002A1 (en) | 1985-11-08 | 1985-11-08 | Process for producing foaming composition |
Publications (1)
Publication Number | Publication Date |
---|---|
WO1987003002A1 true WO1987003002A1 (en) | 1987-05-21 |
Family
ID=13846630
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/JP1985/000625 WO1987003002A1 (en) | 1985-02-07 | 1985-11-08 | Process for producing foaming composition |
Country Status (1)
Country | Link |
---|---|
WO (1) | WO1987003002A1 (en) |
Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS494377B1 (en) * | 1970-08-07 | 1974-01-31 | ||
JPS5126214A (en) * | 1974-08-30 | 1976-03-04 | Tatsumi Kagaku Kk | HATSUHOJONOSEIZOHO |
JPS5626796A (en) * | 1979-08-10 | 1981-03-14 | Nisshin Oil Mills Ltd | Waterrsoluble fertilizer |
JPS56161301A (en) * | 1980-05-19 | 1981-12-11 | Kao Corp | Disinfectant tablet |
JPS5948401A (en) * | 1982-09-10 | 1984-03-19 | Kyushu Sankyo Kk | Agricultural chemical granule having improved disintegration dispersibility |
JPS59219205A (en) * | 1983-05-27 | 1984-12-10 | Nissan Chem Ind Ltd | Production of expandable tablet |
-
1985
- 1985-11-08 WO PCT/JP1985/000625 patent/WO1987003002A1/en unknown
Patent Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS494377B1 (en) * | 1970-08-07 | 1974-01-31 | ||
JPS5126214A (en) * | 1974-08-30 | 1976-03-04 | Tatsumi Kagaku Kk | HATSUHOJONOSEIZOHO |
JPS5626796A (en) * | 1979-08-10 | 1981-03-14 | Nisshin Oil Mills Ltd | Waterrsoluble fertilizer |
JPS56161301A (en) * | 1980-05-19 | 1981-12-11 | Kao Corp | Disinfectant tablet |
JPS5948401A (en) * | 1982-09-10 | 1984-03-19 | Kyushu Sankyo Kk | Agricultural chemical granule having improved disintegration dispersibility |
JPS59219205A (en) * | 1983-05-27 | 1984-12-10 | Nissan Chem Ind Ltd | Production of expandable tablet |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CA2072513C (en) | Lozenge or chewable tablet | |
JP5693635B2 (en) | Orally disintegrating tablet masking bitterness and method for producing the same | |
EP1001748B1 (en) | A process for the preparation of a granulate suitable to the preparation of rapidly disintegrable mouth-soluble tablets | |
KR100358211B1 (en) | Granule products or tablets containing foaming systems and pharmaceutical active substances and methods for making them | |
US4093710A (en) | Rapid dissolving effervescent granules | |
IE892749L (en) | Morphine-containing composition | |
CN104490833B (en) | A kind of Ezetimibe oral disnitegration tablet and preparation method thereof | |
JPS62215536A (en) | Foamable couple, histamine h2 antagonist foamable composition containing same and manufacture | |
JPS61183219A (en) | Production of foamable composition | |
EP1707192B1 (en) | Pharmaceutical composition | |
JPH07501533A (en) | Pharmaceutical compositions based on Ebathyme or its analogues | |
NO315308B1 (en) | Granulated product or tablet containing an effervescent system and an active pharmaceutical substance, and methods for preparing it | |
EP0415326B1 (en) | Composition for foaming preparation | |
JP2508547B2 (en) | Bitterness reduction method and bitterness reduction composition | |
CA2191562A1 (en) | Fast dissolving dosage forms | |
JP2002525092A (en) | Nutrition and pharmaceutical composition | |
US20020127184A1 (en) | Effervescent tablet compositions | |
WO1987003002A1 (en) | Process for producing foaming composition | |
US20040009235A1 (en) | Nanometer grade hydroxyapatite composition for replenishing calcium | |
JP3293524B2 (en) | Ginkgo biloba leaf extract-supported powder composite and method for producing the same | |
JP2004175757A (en) | Medicinal composition | |
ES2320827B1 (en) | "PHARMACEUTICAL COMPOSITION CONTAINING PSYLLIUM AND SENNA". | |
JPH03251525A (en) | Bathing agent | |
JPS6313403B2 (en) | ||
WO1986004599A1 (en) | Process for producing foaming composition |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A1 Designated state(s): MC |
|
CFP | Corrected version of a pamphlet front page |
Free format text: UNDER INID NUMBER (22) "INTERNATIONAL FILING DATE",REPLACE "(081187)" BY "(081185)" |